Reading List

WORK IN PROGRESS

Disclaimer: This is a work in progress. We are conducting a literature review and meta-analysis. Our first steps were to search journal article indices (e.g. Google Scholar, Web of Science) and to retrieve and store citations and full-text articles. Some citations may contain typographical errors or incorrectly captured data. We are working to review and sanitize these references. Full-text documents are not reproduced here to avoid copyright infringement, however DOI identifiers and hyperlinks to the materials are provided where possible. The papers / topics below are selected based on prevalence in the literature and relevance to the general topic of nootropics. Inclusion in the list below in no way implies an endorsement, recommendation or plan to sell any specific supplement or medication.

 

1. Aarsland D. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. Journal of Neurology, Neurosurgery &; Psychiatry. 2002;72(6). doi:10.1136/jnnp.72.6.708

2. Abramets I, Kuznetsov Y, Evdokimov D, Zaika T. Piracetam potentiates neuronal and behavioral effects of ketamine. Research Results in Pharmacology. 2019;5(2). doi:10.3897/rrpharmacology.5.35530

3. Adibhatla R, Hatcher J. Cytidine 5?-Diphosphocholine (CDP-Choline) in Stroke and Other CNS Disorders. Neurochemical Research. 2005;30(1). doi:10.1007/s11064-004-9681-8

4. Adibhatla R, Hatcher J, Tureyen K. CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke. Brain Research. 2005;1058(1-2). doi:10.1016/j.brainres.2005.07.067

5. Adibhatla R, Hatcher J, Larsen E, Chen X, Sun D, Tsao F. CDP-choline Significantly Restores Phosphatidylcholine Levels by Differentially Affecting Phospholipase A2 and CTP: Phosphocholine Cytidylyltransferase after Stroke. Journal of Biological Chemistry. 2006;281(10). doi:10.1074/jbc.m512112200

6. Adriani W, Granstrem O, Romano E, Koroleva S, Laviola G. Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice. The Open Neuropsychopharmacology Journal. 2009;2(1). doi:10.2174/1876523800902010022

7. Agha K, Abo-Dya N, Issahaku A, et al. Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 2022;37(1). doi:10.1080/14756366.2022.2068147

8. Aguiar S, Borowski T. Neuropharmacological Review of the Nootropic Herb iBacopa monnieri/i. Rejuvenation Research. 2013;16(4). doi:10.1089/rej.2013.1431

9. Ahuja C, Fehlings M. Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury. Stem Cells Translational Medicine. 2016;5(7). doi:10.5966/sctm.2015-0381

10. Ahuja C, Mothe A, Khazaei M, et al. The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury. Stem Cells Translational Medicine. 2020;9(12). doi:10.1002/sctm.19-0135

11. Alahmdi M, Syed K, Vanaraj S, et al. In Vitro Anticancer and Antibacterial Activity of Green Synthesized ZnO NPs Using Clitorea Ternatea Flower Extract: Inhibits MCF-7 Cell Proliferation Via Intrinsic Apoptotic Pathway. Published online January 1, 2022. doi:10.21203/rs.3.rs-1269775/v1

12. Alcantara-Gonzalez F, Mendoza-Perez C, Zaragoza N, et al. Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Synapse. 2012;66(11). doi:10.1002/syn.21588

13. Alexander GC, Karlawish J. The problem of aducanumab for the treatment of Alzheimer disease. Annals of Internal Medicine. 2021;174(9):1303-1304.

14. Alsarrani A, Kaplita P. In silico and in vitro evaluation of brain penetration properties of selected nootropic agents. Future Drug Discovery. 2019;1(1). doi:10.4155/fdd-2019-0009

15. Alvarez X, Cacabelos R, Laredo M, et al. A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer’s disease. European journal of neurology. 2006;13(1):43-54.

16. AM A, Uddin M, Wahid F, AI M, Rahman M. Neurodefensive Effect of Olea europaea L. in Alloxan-Induced Cognitive Dysfunction and Brain Tissue Oxidative Stress in Mice: Incredible Natural Nootropic. Journal of Neurology and Neuroscience. 2016;7. doi:10.21767/2171-6625.1000126

17. Amin H, Sharma R. Nootropic efficacy of Satvavajaya Chikitsaand Ayurvedic drug therapy: A comparative clinical exposition. International Journal of Yoga. 2015;8(2). doi:10.4103/0973-6131.158473

18. Anand A. Aducanumab (Aduhelm), a cure to the tragedy of Alzheimer’s Disease?

19. Anders P, Davis E. Oral health of patients with intellectual disabilities: A systematic review. Special Care in Dentistry. 2010;30(3). doi:10.1111/j.1754-4505.2010.00136.x

20. Andreasen N, Minthon L, Davidsson P, et al. Evaluation of CSF-tau and CSF-A\upbeta42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice. Archives of Neurology. 2001;58(3). doi:10.1001/archneur.58.3.373

21. Anikina L, Gazieva G, Kravchenko A. Nootropic activity of N-(2-acetylaminoethyl)glycolurils. Russian Chemical Bulletin. 2020;69(3). doi:10.1007/s11172-020-2799-2

22. Antón Álvarez X, Fuentes P. Cerebrolysin in Alzheimer’s disease. Drugs Today (Barc). 2011;47(7):487-513. doi:10.1358/dot.2011.47.7.1656496

23. Arenth P, Russell K, Ricker J, Zafonte R. CDP-Choline as a Biological Supplement During Neurorecovery: A Focused Review. PM&;R. 2011;3. doi:10.1016/j.pmrj.2011.03.012

24. Asztely F, Hanse E, Wigström H, Gustafsson B. Aniracetam-evoked potentiation does not interact with long-term potentiation in the CA1 region of the hippocampus. Synapse. 1992;11(4). doi:10.1002/syn.890110409

25. Bae C, Cho C, Cho K, et al. A double‐blind, placebo‐controlled, multicenter study of cerebrolysin for Alzheimer’s disease. Journal of the American Geriatrics Society. 2000;48(12):1566-1571.

26. Bang HJ, Kim IH, Kim B. Phospholipase A 1 -catalyzed hydrolysis of soy phosphatidylcholine to prepare l -α-glycerylphosphorylcholine in organic-aqueous media. Food Chemistry. 2016;190. doi:10.1016/j.foodchem.2015.05.093

27. Bao H, Zhang J, Yeo S, et al. Memory enhancing and neuroprotective effects of selected ginsenosides. Archives of Pharmacal Research. 2005;28(3). doi:10.1007/bf02977802

28. Baranova A, Whiting M, Hamm R. Delayed, Post-Injury Treatment with Aniracetam Improves Cognitive Performance after Traumatic Brain Injury in Rats. Journal of Neurotrauma. 2006;23(8). doi:10.1089/neu.2006.23.1233

29. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid B-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine. 2000;6(8). doi:10.1038/78682

30. Barnes L, Wilson R, Bienias J, Schneider J, Evans D, Bennett D. Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology. Archives of General Psychiatry. 2005;62(6). doi:10.1001/archpsyc.62.6.685

31. Bartus RT, Dean III RL, Sherman KA, Friedman E, Beer B. Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiology of aging. 1981;2(2):105-111.

32. Beach T, Monsell S, Phillips L, Kukull W. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. Journal of Neuropathology &; Experimental Neurology. 2012;71(4). doi:10.1097/nen.0b013e31824b211b

33. Beadle-Brown J, Mansell J, Kozma A. Deinstitutionalization in intellectual disabilities. Current Opinion in Psychiatry. 2007;20(5). doi:10.1097/yco.0b013e32827b14ab

34. Becerra G, Tatko L, Pak E, Murashov A, Hoane M. Transplantation of GABAergic neurons but not astrocytes induces recovery of sensorimotor function in the traumatically injured brain. Behavioural Brain Research. 2007;179(1). doi:10.1016/j.bbr.2007.01.024

35. Belaguli G, Nithin S, Mohan K. Customized Ayurveda approaches in modulating brain injury: A case report. Journal of Ayurveda Case Reports. 2022;5(2). doi:10.4103/jacr.jacr_71_21

36. Belenichev I, Gorbacheva S, Demchenko A, Bukhtiyarova N. The thiol-disulfide balance and the nitric oxide system in the brain tissue of rats subjected to experimental acute impairment of cerebral blood flow: The therapeutic effects of nootropic drugs. Neurochemical Journal. 2014;8(1). doi:10.1134/s181971241401005x

37. Bennett D, Schneider J, Wilson R, Bienias J, Arnold S. Neurofibrillary Tangles Mediate the Association of Amyloid Load With Clinical Alzheimer Disease and Level of Cognitive Function. Archives of Neurology. 2004;61(3). doi:10.1001/archneur.61.3.378

38. Bhosale U, Somani R, Talpate K, Zambare M. Neuroprotective and nootropic activity of Clitorea ternatea Linn.(Fabaceae) leaves on diabetes induced cognitive decline in experimental animals. Journal of Pharmacy and Bioallied Sciences. 2014;6(1). doi:10.4103/0975-7406.124317

39. Bianchi V, Locatelli V, Rizzi L. Neurotrophic and Neuroregenerative Effects of GH/IGF1. International Journal of Molecular Sciences. 2017;18(11). doi:10.3390/ijms18112441

40. Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database of Systematic Reviews. Published online July 1, 2006. doi:10.1002/14651858.cd006104

41. Birks J, Harvey R. Donepezil for dementia due to Alzheimer’s disease. Published online July 1, 2003. doi:10.1002/14651858.cd001190

42. Bishop S. Neurocognitive mechanisms of anxiety: an integrative account. Trends in Cognitive Sciences. 2007;11(7). doi:10.1016/j.tics.2007.05.008

43. Bizzarri M, Minini M, Monti N. Revisiting the Concept of Human Disease. Published online 2020. doi:10.1007/978-3-030-32857-3_1

44. Blin O, Audebert C, Pitel S, et al. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology. 2009;207(2). doi:10.1007/s00213-009-1648-7

45. Bobinski F, Martins D, Bratti T, et al. Neuroprotective and neuroregenerative effects of low-intensity aerobic exercise on sciatic nerve crush injury in mice. Neuroscience. 2011;194. doi:10.1016/j.neuroscience.2011.07.075

46. Bobkov Yu, Morozov I, Glozman O, Nerobkova L, Zhmurenko L, Zagorevskii V. Pharmacological characteristics of 4-phenylpiracetam ? A new phenyl analog of piracetam. Bulletin of Experimental Biology and Medicine. 1983;95(4). doi:10.1007/bf00838859

47. Böckmann K, Franz A, Minarski M, et al. Differential metabolism of choline supplements in adult volunteers. European Journal of Nutrition. 2021;61(1). doi:10.1007/s00394-021-02637-6

48. Bolla K, Brown K, Eldreth D, Tate K, Cadet J. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59(9). doi:10.1212/01.wnl.0000031422.66442.49

49. Bressler S, Tognoli E. Operational principles of neurocognitive networks. International Journal of Psychophysiology. 2006;60(2). doi:10.1016/j.ijpsycho.2005.12.008

50. Bright J, Smith C, Taylor P, Crook R. Stochastic generation of synthetic minutely irradiance time series derived from mean hourly weather observation data. Solar Energy. 2015;115. doi:10.1016/j.solener.2015.02.032

51. Brock J, Golding D, Smith P, Nokes L, Kwan A, Lee P. Update on the Role of Actovegin in Musculoskeletal Medicine. Clinical Journal of Sport Medicine. 2018;Publish Ahead of Print. doi:10.1097/jsm.0000000000000566

52. Brody D, Holtzman D. Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Experimental Neurology. 2006;197(2). doi:10.1016/j.expneurol.2005.10.020

53. Bryan J. Psychological effects of dietary components of tea: caffeine and L-theanine. Nutrition Reviews. 2008;66(2). doi:10.1111/j.1753-4887.2007.00011.x

54. Buchmayer F, Pleiner J, Elmlinger M, Lauer G, Nell G, Sitte H. Actovegin®: a biological drug for more than 5 decades. Wiener Medizinische Wochenschrift. 2011;161(3-4). doi:10.1007/s10354-011-0865-y

55. Buchnat M, Wojciechowska A. Online education of students with mild intellectual disability and autism spectrum disorder during the COVID-19 pandemic. Interdyscyplinarne Konteksty Pedagogiki Specjalnej. 2020;(29). doi:10.14746/ikps.2020.29.07

56. Butterfield D, Hensley K, Harris M, Mattson M, Carney J. \upbeta-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer\primes Disease. Biochemical and Biophysical Research Communications. 1994;200(2). doi:10.1006/bbrc.1994.1508

57. Cabero T, Sarmiento R. Estudio de suceptibilidad genetica a la degeneracion macular asociada a la edad (DMAE). FarmaJournal. 2020;5(2). doi:10.14201/fj2020526372

58. Cai Q, Zhong S, Chen K. Target Detection in Rural River Image Based on Yolo V5 Model with the Cross-Stitch Unit. Published online July 1, 2021. doi:10.1109/icivc52351.2021.9527005

59. Cakic V. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics. 2009;35(10). doi:10.1136/jme.2009.030882

60. Caner B, Kafa M, Bekar A, et al. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Neurological Research. 2012;34(3). doi:10.1179/1743132812y.0000000003

61. Cansev M, Ilcol Y, Yilmaz M, Hamurtekin E, Ulus I. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Autonomic &; Autacoid Pharmacology. 2008;28(1). doi:10.1111/j.1474-8673.2007.00416.x

62. Cansev M, Watkins C, Beek E, Wurtman R. Oral uridine-5\prime-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Research. 2005;1058(1-2). doi:10.1016/j.brainres.2005.07.054

63. Cansev M, Yilmaz M, Ilcol Y, Hamurtekin E, Ulus I. Cardiovascular effects of CDP-choline and its metabolites: Involvement of peripheral autonomic nervous system. European Journal of Pharmacology. 2007;577(1-3). doi:10.1016/j.ejphar.2007.08.029

64. Carpino L. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. Journal of the American Chemical Society. 1993;115(10). doi:10.1021/ja00063a082

65. Cauwenberghe C, Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genetics in Medicine. 2016;18(5). doi:10.1038/gim.2015.117

66. Cenini G, Voos W. Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update. Frontiers in Pharmacology. 2019;10. doi:10.3389/fphar.2019.00902

67. Chakraborty S, Khan G, Karmohapatra S, Bhattacharya R, Bhattacharya G, Sinha A. Purification and mechanism of action of “cortexin,” a novel antihypertensive protein hormone from kidney and its role in essential hypertension in men. Journal of the American Society of Hypertension. 2009;3(2). doi:10.1016/j.jash.2008.11.002

68. Chang E, Goldberg J. Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement. Ophthalmology. 2012;119(5). doi:10.1016/j.ophtha.2011.11.003

69. Chaudhari K, Tiwari N, Tiwari R, Sharma R. Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer’s Disease. Annals of Neurosciences. 2017;24(2). doi:10.1159/000475900

70. Chaudhari V, G M. A Critical Review of Role of Medhya Dravyas (Nootropic Drugs) in Brain Fog with special reference to Covid- 19. International Journal of Ayurveda and Pharma Research. Published online October 1, 2022. doi:10.47070/ijapr.v10i9.2526

71. Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biology. 2018;14. doi:10.1016/j.redox.2017.10.014

72. Chen CC, Wei ST, Tsaia SC, Chen XX, Cho DY. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study. British journal of neurosurgery. 2013;27(6):803-807.

73. Chen Z, Huan G, Ma Y. Computational Methods for Multiphase Flows in Porous Media. Published online January 1, 2006. doi:10.1137/1.9780898718942

74. Chen Z, Ji H, Liu C, Bing W, Wang Z, Qu X. A Multinuclear Metal Complex Based DNase-Mimetic Artificial Enzyme: Matrix Cleavage for Combating Bacterial Biofilms. Angewandte Chemie. 2016;128(36). doi:10.1002/ange.201605296

75. Chernichovsky D, Zangwill L. Micro-Economic Theory of the Household and Nutrition Programmes. Food and Nutrition Bulletin. 1990;12(1). doi:10.1177/156482659001200124

76. Chicoine B, Head E, Janicki J. Aduhelm: Rush to judgement? Exceptional Parent. Published online 2021.

77. Cho C, Aardema N, Bunnell M, et al. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men. Nutrients. 2020;12(8). doi:10.3390/nu12082220

78. Cho HS, Kim S, Lee SY, Park J, Kim SJ, Chun H. Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death. NeuroToxicology. 2008;29(4). doi:10.1016/j.neuro.2008.03.004

79. Chou J, Harvey B, Chang CF, Shen H, Morales M, Wang Y. Neuroregenerative effects of BMP7 after stroke in rats. Journal of the Neurological Sciences. 2006;240(1-2). doi:10.1016/j.jns.2005.08.015

80. Chui H, Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimer's Research &; Therapy. 2015;7(1). doi:10.1186/s13195-015-0104-7

81. Chung J, Torta F, Masai K, et al. PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-plasma membrane contacts. Science. 2015;349(6246). doi:10.1126/science.aab1370

82. Ciarlet P. The Finite Element Method for Elliptic Problems. Published online January 1, 2002. doi:10.1137/1.9780898719208

83. Citradewi P, Hidayat H, Purwiandono G, Fatimah I, Sagadevan S. Clitorea ternatea-mediated silver nanoparticle-doped hydroxyapatite derived from cockle shell as antibacterial material. Chemical Physics Letters. 2021;769. doi:10.1016/j.cplett.2021.138412

84. Clarfield A. Book Review Concepts of Alzheimer Disease: Biological, clinical, and cultural perspectives Edited by Peter J. Whitehouse, Konrad Maurer, and Jesse F. Ballenger. 341 pp., illustrated. Baltimore, Johns Hopkins University Press, 2000. 55. 0-8018-6233-7. New England Journal of Medicine. 2000;343(13). doi:10.1056/nejm200009283431317

85. Clausen F, Haanell A, Israelsson C, et al. Neutralization of interleukin-1\upbeta reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. European Journal of Neuroscience. 2011;34(1). doi:10.1111/j.1460-9568.2011.07723.x

86. Cobb J, Eckhart A, Motsinger-Reif A, Carr B, Groop L, Ferrannini E. α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance. Diabetes Care. 2016;39(6). doi:10.2337/dc15-2752

87. Cohen S, Mutter W. Effects of Piracetam on N-Methyl-\<i\>D\</i\>-Aspartate Receptor Properties in the Aged Mouse Brain. Pharmacology. 1993;47(4). doi:10.1159/000139100

88. Concepcion E, Gomez-Hernandez Angel, Martin M, Segovia J. Density and viscosity measurements of aqueous amines at high pressures: DEA-water, DMAE-water and TEA-water mixtures. The Journal of Chemical Thermodynamics. 2017;112. doi:10.1016/j.jct.2017.05.001

89. Cossi M, Barone V. Time-dependent density functional theory for molecules in liquid solutions. The Journal of Chemical Physics. 2001;115(10). doi:10.1063/1.1394921

90. Courtenay K, Perera B. COVID-19 and people with intellectual disability: impacts of a pandemic. Irish Journal of Psychological Medicine. 2020;37(3). doi:10.1017/ipm.2020.45

91. Crescenzi O, Tomaselli S, Guerrini R, et al. Solution structure of the Alzheimer amyloid \upbeta-peptide (1-42) in an apolar microenvironment. European Journal of Biochemistry. 2002;269(22). doi:10.1046/j.1432-1033.2002.03271.x

92. Cui R, Ding J, Chen Y. Magnesium acrylate induced interfacial compatibilization of EPDM/PP thermoplastic vulcanizate and shape memory behavior. Composites Part A: Applied Science and Manufacturing. 2019;122. doi:10.1016/j.compositesa.2019.04.016

93. Cummins R, Lau A. Community Integration or Community Exposure? A Review and Discussion in Relation to People with an Intellectual Disability. Journal of Applied Research in Intellectual Disabilities. 2003;16(2). doi:10.1046/j.1468-3148.2003.00157.x

94. D’yakonova I, Ishanova Yu, Rakhmanova I. Otoprotective Effect of Cortexin, Cogitum, and Elkar Administered Simultaneously with Netromycin in the Experiment. Bulletin of Experimental Biology and Medicine. 2020;169(4). doi:10.1007/s10517-020-04908-4

95. Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information. Archives of Neurology. 2000;57(5). doi:10.1001/archneur.57.5.675

96. Danysz W, Parsons C. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. International Journal of Geriatric Psychiatry. 2003;18(S1). doi:10.1002/gps.938

97. Dartigues JF, Carcaillon L, Helmer C, Lechevallier N, Lafuma A, Khoshnood B. Vasodilators and Nootropics as Predictors of Dementia and Mortality in the PAQUID Cohort. Journal of the American Geriatrics Society. 2007;55(3). doi:10.1111/j.1532-5415.2007.01084.x

98. Das N, Kim M, Rani J, Hong SM, Jang JH. Electroforming-Free Bipolar Resistive Switching Memory Based on Magnesium Fluoride. Micromachines. 2021;12(9). doi:10.3390/mi12091049

99. Dash P, Orsi S, Moore A. Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience. 2009;163(1). doi:10.1016/j.neuroscience.2009.06.028

100. Dash P, Zhao J, Orsi S, Zhang M, Moore A. Sulforaphane improves cognitive function administered following traumatic brain injury. Neuroscience Letters. 2009;460(2). doi:10.1016/j.neulet.2009.04.028

101. De Deyn PP, De Reuck J, Deberdt W, Vlietinck R, Orgogozo JM. Treatment of acute ischemic stroke with piracetam. Stroke. 1997;28(12):2347-2352.

102. Deb S, Chaplin R, Sohanpal S, Unwin G, Soni R, Lenotre L. The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review. Journal of Intellectual Disability Research. 2007;0(0). doi:10.1111/j.1365-2788.2007.00965.x

103. DeFina P, Moser R, Glenn M, Lichtenstein J, Fellus J. Alzheimer's Disease Clinical and Research Update for Health Care Practitioners. Journal of Aging Research. 2013;2013. doi:10.1155/2013/207178

104. Demchenko A, Belenichev I. Efficiency of cortexin under the conditions of experimental chronic brain ischemia. Neurochemical Journal. 2016;10(1). doi:10.1134/s1819712416010050

105. Dennehy H, Allen A, McGlinchey E, et al. A scoping review of post-diagnostic dementia supports for people with intellectual disability. Aging &; Mental Health. Published online October 1, 2022. doi:10.1080/13607863.2022.2130171

106. Derev’yannykh E, Bel’skaya G, Knoll E, Krylova L, Popov D. Experience in the use of actovegin in the treatment of patients with cognitive disorders in the acute period of stroke. Neuroscience and Behavioral Physiology. 2008;38(8). doi:10.1007/s11055-008-9051-0

107. DeTure M, Dickson D. The neuropathological diagnosis of Alzheimer’s disease. Molecular Neurodegeneration. 2019;14(1). doi:10.1186/s13024-019-0333-5

108. Dhanasekaran M. Evaluation of Nootropic Activity of Ethanolic Extract of iArdisia blatteri/i using Different Experimental Models in Rats. Asian Journal of Research in Pharmaceutical Science. 2019;9(4). doi:10.5958/2231-5659.2019.00041.9

109. Diaz-Arrastia R, Agostini M, Madden C, Ness P. Posttraumatic epilepsy: The endophenotypes of a human model of epileptogenesis. Epilepsia. 2009;50. doi:10.1111/j.1528-1167.2008.02006.x

110. DiBella M, Thomas M, Alyousef H, et al. Choline Intake as Supplement or as a Component of Eggs Increases Plasma Choline and Reduces Interleukin-6 without Modifying Plasma Cholesterol in Participants with Metabolic Syndrome. Nutrients. 2020;12(10). doi:10.3390/nu12103120

111. Dieckmann A, Kriebel M, Andriambeloson E, Ziegler D, Elmlinger M. Treatment with Actovegin® Improves Sensory Nerve Function and Pathology in Streptozotocin-Diabetic Rats via Mechanisms Involving Inhibition of PARP Activation. Experimental and Clinical Endocrinology & Diabetes. 2011;120(03). doi:10.1055/s-0031-1291248

112. Dietrich A. Neurocognitive mechanisms underlying the experience of flow. Consciousness and Cognition. 2004;13(4). doi:10.1016/j.concog.2004.07.002

113. Ditchman N, Werner S, Kosyluk K, Jones N, Elg B, Corrigan P. Stigma and intellectual disability: Potential application of mental illness research. Rehabilitation Psychology. 2013;58(2). doi:10.1037/a0032466

114. Ditter S, Mirra S. Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Alzheimer Disease &; Associated Disorders. 1987;1(4). doi:10.1097/00002093-198701040-00011

115. Dodart JC, Bales K, Gannon K, et al. Immunization reverses memory deficits without reducing brain A\upbeta burden in Alzheimer's disease model. Nature Neuroscience. 2002;5(5). doi:10.1038/nn842

116. Donega V, Nijboer C, Braccioli L, et al. Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions. PLoS ONE. 2014;9(11). doi:10.1371/journal.pone.0112339

117. Doody R, Ferris S, Salloway S, et al. Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial. Neurology. 2009;72(18). doi:10.1212/01.wnl.0000344650.95823.03

118. Dooley M, Lamb H. Donepezil. Drugs &; Aging. 2000;16(3). doi:10.2165/00002512-200016030-00005

119. Doyno C, White C. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. The Journal of Clinical Pharmacology. 2021;61(S2). doi:10.1002/jcph.1922

120. Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid ~-peptide antibody in Alzheimer disease. Neurology. 2001;57(5). doi:10.1212/wnl.57.5.801

121. Duan XF, Wang CC, Xue CH, Zhang TT, Wang YM. Trimethylamine iN/i-Oxide Generation from Choline-Containing Precursors Is Closely Associated with Their Molecular Structure. Journal of Agricultural and Food Chemistry. 2021;69(10). doi:10.1021/acs.jafc.1c01068

122. Ehret M, Chamberlin K. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Clinical Therapeutics. 2015;37(8). doi:10.1016/j.clinthera.2015.05.510

123. Einfeld S, Piccinin A, Mackinnon A, et al. Psychopathology in Young People With Intellectual Disability. JAMA. 2006;296(16). doi:10.1001/jama.296.16.1981

124. Elmlinger M, Kriebel M, Ziegler D. Neuroprotective and Anti-Oxidative Effects of the Hemodialysate Actovegin on Primary Rat Neurons in Vitro. NeuroMolecular Medicine. 2011;13(4). doi:10.1007/s12017-011-8157-7

125. Elston T, Pandian A, Smith G, Holley A, Gao N, Lugo J. Aniracetam Does Not Alter Cognitive and Affective Behavior in Adult C57BL/6J Mice. PLoS ONE. 2014;9(8). doi:10.1371/journal.pone.0104443

126. Enciu A, Nicolescu M, Manole C, Muresanu D, Popescu L, Popescu B. Neuroregeneration in neurodegenerative disorders. BMC Neurology. 2011;11(1). doi:10.1186/1471-2377-11-75

127. Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study. Clinical neuropharmacology. 1994;17(4):320-331.

128. Ennaceur A, Cavoy A, Costa JC, Delacour J. A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam. Behavioural brain research. 1989;33(2):197-207.

129. Erickson C, Posey D, Stigler K, Mullett J, Katschke A, McDougle C. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology. 2006;191(1). doi:10.1007/s00213-006-0518-9

130. Erll A. Memory in Culture. Published online 2011. doi:10.1057/9780230321670

131. Evenhuis H. Medical aspects of ageing in a population with intellectual disability: III. Mobility, internal conditions and cancer. Journal of Intellectual Disability Research. 2007;41(1). doi:10.1111/j.1365-2788.1997.tb00672.x

132. Fabbro A, Prato M, Ballerini L. Carbon nanotubes in neuroregeneration and repair. Advanced Drug Delivery Reviews. 2013;65(15). doi:10.1016/j.addr.2013.07.002

133. Fagone P, Jackowski S. Phosphatidylcholine and the CDP-choline cycle. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2013;1831(3). doi:10.1016/j.bbalip.2012.09.009

134. Fan W, Li X, Huang L, et al. S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K / Akt / GSK3\upbeta signal pathway in rats. Neurochemistry International. 2018;115. doi:10.1016/j.neuint.2018.01.008

135. Fan W, Zhang Y, Li X, Xu C. S-oxiracetam Facilitates Cognitive Restoration after Ischemic Stroke by Activating α7nAChR and the PI3K-Mediated Pathway. Neurochemical Research. 2021;46(4). doi:10.1007/s11064-021-03233-0

136. Farah M, Illes J, Cook-Deegan R, et al. Neurocognitive enhancement: what can we do and what should we do? Nature Reviews Neuroscience. 2004;5(5). doi:10.1038/nrn1390

137. Farlow M, Cummings J. Effective Pharmacologic Management of Alzheimer’s Disease. The American Journal of Medicine. 2007;120(5). doi:10.1016/j.amjmed.2006.08.036

138. Fedin A, Belskaya G, Kurushina O, et al. Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study). Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2018;118(9). doi:10.17116/jnevro201811809135

139. Ferrannini E, Natali A, Camastra S, et al. Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance. Diabetes. 2013;62(5). doi:10.2337/db12-0707

140. Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology. 2017;8. doi:10.3389/fphar.2017.00089

141. Filho E. Letter to the Editor: Early seizure prophylaxis in pediatric severe traumatic brain injury: still a long way to go. Journal of Neurosurgery: Pediatrics. 2017;19(3). doi:10.3171/2016.7.peds16384

142. Filippenkov I, Stavchansky V, Denisova A, et al. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes. 2020;11(6). doi:10.3390/genes11060681

143. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Published online April 1, 2004. doi:10.1002/14651858.cd000269.pub2

144. Firan F, Romila A, Onose G. Current Synthesis and Systematic Review of Main Effects of Calf Blood Deproteinized Medicine (Actovegin\textregistered) in Ischemic Stroke. International Journal of Molecular Sciences. 2020;21(9). doi:10.3390/ijms21093181

145. Fisher R, Geiselman R. Expanding the Cognitive Interview to Non-Criminal Investigations. Published online February 1, 2019. doi:10.4324/9781315160276-1

146. Fleur P, Baizhaxynova A, Reynen E, Kaunelis D, Galiyeva D. Actovegin in the management of patients after ischemic stroke: A systematic review. PLOS ONE. 2022;17(6). doi:10.1371/journal.pone.0270497

147. Flicker L, Evans JG. Piracetam for dementia or cognitive impairment. Cochrane Database of Systematic Reviews. 2004;(1).

148. Folch J, Busquets O, Ettcheto M, et al. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. Journal of Alzheimer's Disease. 2018;62(3). doi:10.3233/jad-170672

149. Food, Administration D. Aducanumab (marketed as Aduhelm) information. Published online 2021.

150. Francis-Turner L, Valouskova V, Mokry J. The long-term effect of NGF, b-FGF and Cerebrolysin® on the spatial memory after fimbria-fornix lesion in rats. In: New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia. Springer; 1996:277-277.

151. Francis-Turner L, Valoušková V. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Neuroscience letters. 1996;202(3):193-196.

152. Fresina M, Dickmann A, Salerni A, Gregorio F, Campos E. Effect of oral CDP-choline on visual function in young amblyopic patients. Graefe's Archive for Clinical and Experimental Ophthalmology. 2007;246(1). doi:10.1007/s00417-007-0621-6

153. Friedman M. Chemistry, Nutrition, and Health-Promoting Properties ofiHericium erinaceus/i(Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. Journal of Agricultural and Food Chemistry. 2015;63(32). doi:10.1021/acs.jafc.5b02914

154. Frisoni G, Fox N, Jack C, Scheltens P, Thompson P. The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology. 2010;6(2). doi:10.1038/nrneurol.2009.215

155. Froestl W, Muhs A, Pfeifer A. Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Journal of Alzheimer's Disease. 2013;33(3). doi:10.3233/jad-2012-121537

156. Fromholt P, Larsen S. Autobiographical Memory and Life-history Narratives in Aging and Dementia (Alzheimer type). Published online 1992. doi:10.1007/978-94-015-7967-4_24

157. Fu T ting, Tu G, Ping M, et al. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacologica Sinica. 2020;42(8). doi:10.1038/s41401-020-00541-z

158. Funke M, Fiehler J, Mewes I, Eiselt M, Rother I, Windisch M. Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia. In: Ageing and Dementia. Springer; 1998:385-398.

159. Gallagher S, Phillips A, Oliver C, Carroll D. Predictors of Psychological Morbidity in Parents of Children with Intellectual Disabilities. Journal of Pediatric Psychology. 2008;33(10). doi:10.1093/jpepsy/jsn040

160. Ganapolsky V, Shabanov P. Nootropic and peptide drugs possess meteoadaptogenic properties in healthy volunteers. Published online 2008. doi:10.1037/e516202012-062

161. Ganguly R. Effect of Moringa Oleifera in Experimental Model of Alzheimer's Disease : Role of Antioxidants. Annals of neurosciences. 2005;12(3). doi:10.5214/ans.0972.7531.2005.120301

162. Gangurde A, Fule R, Javeer S, Patole R, Pawar J, Amin P. Microencapsulation using aqueous dispersion of lipid matrix by fluidized bed processing technique for stabilization of choline salt. Journal of Pharmaceutical Investigation. 2014;45(2). doi:10.1007/s40005-014-0167-7

163. Gangurde A, Sav A, Javeer S, Moravkar K, Pawar J, Amin P. Modified extrusion-spheronization as a technique of microencapsulation for stabilization of choline bitartrate using hydrogenated soya bean oil. International Journal of Pharmaceutical Investigation. 2015;5(4). doi:10.4103/2230-973x.167696

164. GAO J, PROUGH D, MCADOO D, et al. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Experimental Neurology. 2006;201(2). doi:10.1016/j.expneurol.2006.04.039

165. Gates N, Sachdev P. Is Cognitive Training an Effective Treatment for Preclinical and Early Alzheimer's Disease? Journal of Alzheimer's Disease. 2014;42(s4). doi:10.3233/jad-141302

166. Gavrilova S, Alvarez A. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use. Medicinal Research Reviews. 2020;41(5). doi:10.1002/med.21722

167. Gelabert-Gonzalez M, Aran-Echabe E, Santin-Amo J. Letter to the Editor: Cranial vault remodeling. Journal of Neurosurgery: Pediatrics. 2017;19(3). doi:10.3171/2016.9.peds16550

168. Genina E, Bashkatov A, Tuchin V, Ghosn M, Larin K, Kamenskikh T. Cortexin diffusion in human eye sclera. Quantum Electronics. 2011;41(5). doi:10.1070/qe2011v041n05abeh014641

169. Ghia N, Spong C, Starbuck V, Scialli A, Ghidini A. Magnesium sulfate therapy affects attention and working memory in patients undergoing preterm labor. American Journal of Obstetrics and Gynecology. 2000;183(4). doi:10.1067/mob.2000.109045

170. Ghosh R, Bhattacharyya M, Khan G, et al. \&:x0D; Diagnosis of Essential Hypertension in Humans by the Determination of Plasma Renal Cortexin using Enzyme-Linked Immunosorbent Assay. Clinical Laboratory. 2013;59(05$\mathplus$06/2013). doi:10.7754/clin.lab.2012.120633

171. Giesbrecht T, Rycroft J, Rowson M, Bruin E. The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness. Nutritional Neuroscience. 2010;13(6). doi:10.1179/147683010x12611460764840

172. Glade M, Smith K. Phosphatidylserine and the human brain. Nutrition. 2015;31(6). doi:10.1016/j.nut.2014.10.014

173. Glavaski-Joksimovic A, Bohn M. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Experimental Neurology. 2013;247. doi:10.1016/j.expneurol.2013.03.016

174. Glazova N, Sebentsova E, Manchenko D, et al. The Protective Effect of Semax in a Model of Stress-Induced Impairment of Memory and Behavior in White Rats. Biology Bulletin. 2018;45(4). doi:10.1134/s1062359018040040

175. Glazova N, Manchenko D, Volodina M, et al. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Neuropeptides. 2021;86. doi:10.1016/j.npep.2020.102114

176. Goldsmith S, McDowell A. Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-\upbeta-Cyclodextrin Suitable for Parenteral Administration. Pharmaceutics. 2018;10(4). doi:10.3390/pharmaceutics10040240

177. Gomazkov O. Cortexin. Molecular mechanisms and targets of neuroprotective activity. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2015;115(8). doi:10.17116/jnevro20151158199-104

178. Goodey C. A History of Intelligence and 'Intellectual Disability'. Published online March 1, 2016. doi:10.4324/9781315564838

179. Gouliaev AH, Senning A. Piracetam and other structurally related nootropics. Brain research reviews. 1994;19(2):180-222.

180. Granata A, Nicoletti R, Tinaglia V, et al. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer. British Journal of Cancer. 2013;110(2). doi:10.1038/bjc.2013.729

181. Grasso S, Bramanti V, Tomassoni D, et al. Effect of lipoic acid and α-glyceryl-phosphoryl-choline on astroglial cell proliferation and differentiation in primary culture. Journal of Neuroscience Research. 2013;92(1). doi:10.1002/jnr.23289

182. Greig N, Utsuki T, Ingram D, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \upbeta-amyloid peptide in rodent. Proceedings of the National Academy of Sciences. 2005;102(47). doi:10.1073/pnas.0508575102

183. Grossberg G, Thomas S. Memantine: a review of studies into its safety and efficacy in treating Alzheimer&;rsquo;s disease and other dementias. Clinical Interventions in Aging. Published online September 1, 2009. doi:10.2147/cia.s6666

184. Grossman R. The Role of Dimethylaminoethanol in Cosmetic Dermatology. American Journal of Clinical Dermatology. 2005;6(1). doi:10.2165/00128071-200506010-00005

185. Grundman M. Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials. Archives of Neurology. 2004;61(1). doi:10.1001/archneur.61.1.59

186. Gualtieri F. Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings. Journal of Enzyme Inhibition and Medicinal Chemistry. 2015;31(2). doi:10.3109/14756366.2015.1021252

187. Guandalini L, Martino M, Mannelli L, et al. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235. Bioorganic &; Medicinal Chemistry Letters. 2015;25(8). doi:10.1016/j.bmcl.2015.03.009

188. Guekht AB, Moessler H, Novak PH, Gusev EI, Cerebrolysin Investigators. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. Journal of Stroke and Cerebrovascular Diseases. 2011;20(4):310-318.

189. Guekht A, Skoog I, Korczyn A, Zakharov V, Eeg M, Vigonius U. A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design. Dementia and Geriatric Cognitive Disorders Extra. 2013;3(1). doi:10.1159/000357122

190. Gulyaeva N. Molecular mechanisms of brain peptide-containing drugs: cortexin. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2018;118(10). doi:10.17116/jnevro201811810193

191. Gummies M. [RETRACTED] Myco Nootropic Brain Gummies (Shocking!) Does Myco Nootropic Brain Really Works? v1. Published online July 1, 2022. doi:10.17504/protocols.io.ewov1nwrygr2/v1

192. Guo X, Song C, Ho CT, Wan X. Contribution of l-theanine to the formation of 2,5-dimethylpyrazine, a key roasted peanutty flavor in Oolong tea during manufacturing processes. Food Chemistry. 2018;263. doi:10.1016/j.foodchem.2018.04.117

193. Guralnick M. Early Intervention for Children with Intellectual Disabilities: Current Knowledge and Future Prospects. Journal of Applied Research in Intellectual Disabilities. 2005;18(4). doi:10.1111/j.1468-3148.2005.00270.x

194. Gurun M, Parker R, Eisenach J, Vincler M. The Effect of Peripherally Administered CDP-Choline in an Acute Inflammatory Pain Model: The Role of α7 Nicotinic Acetylcholine Receptor. Anesthesia &; Analgesia. 2009;108(5). doi:10.1213/ane.0b013e31819dcd08

195. Gusev E, Martynov M, Kostenko E, Petrova L, Bobyreva S. The efficacy of semax in the tretament of patients at different stages of ischemic stroke. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2018;118(3). doi:10.17116/jnevro20181183261-68

196. Gustavsson E, Raaschou P, Lärfars G, Sandman L, Juth N. The ethics of disease-modifying drugs targeting Alzheimer disease: response to our commentators. Journal of Medical Ethics. 2022;48(3):193-193.

197. Gutierrez-Fernandez M, Rodriguez-Frutos B, Fuentes B, et al. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochemistry International. 2012;60(3). doi:10.1016/j.neuint.2011.12.015

198. Hadanny A, Rittblat M, Bitterman M, et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients - a retrospective analysis. Restorative Neurology and Neuroscience. 2020;38(1). doi:10.3233/rnn-190959

199. Hall P. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ. 2004;328(7430). doi:10.1136/bmj.328.7430.19

200. Hamann S, Ely T, Grafton S, Kilts C. Amygdala activity related to enhanced memory for pleasant and aversive stimuli. Nature Neuroscience. 1999;2(3). doi:10.1038/6404

201. Hampel H, Mesulam M, Cuello A, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018;141(7). doi:10.1093/brain/awy132

202. Hanshaw R, Smith B. New reagents for phosphatidylserine recognition and detection of apoptosis. Bioorganic &; Medicinal Chemistry. 2005;13(17). doi:10.1016/j.bmc.2005.04.071

203. Harris J. The Classification of Intellectual Disability. Published online November 1, 2005. doi:10.1093/oso/9780195178852.003.0006

204. Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. Journal of neural transmission. 2001;108(4):459-473.

205. Haskell C, Kennedy D, Milne A, Wesnes K, Scholey A. The effects of l-theanine, caffeine and their combination on cognition and mood. Biological Psychology. 2008;77(2). doi:10.1016/j.biopsycho.2007.09.008

206. Hassan S, Ahmed S, Helmy A, Youssef N. Spectrofluorimetric study on fluorescence quenching of tyrosine and l -tryptophan by the aniracetam cognition enhancer drug: quenching mechanism using Stern-Volmer and double-log plots. Luminescence. 2020;35(5). doi:10.1002/bio.3778

207. Hastings R, Beck A. Practitioner Review: Stress intervention for parents of children with intellectual disabilities. Journal of Child Psychology and Psychiatry. 2004;45(8). doi:10.1111/j.1469-7610.2004.00357.x

208. Hathat Y, Samai D, Benlamoudi A, Bensid K, Taleb-Ahmed A. SNCF workers detection in the railway environment based on improved YOLO v5. Published online May 1, 2022. doi:10.1109/ispa54004.2022.9786027

209. He X, Wang X, Fang J, et al. Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s Mane) mushroom: A review. International Journal of Biological Macromolecules. 2017;97. doi:10.1016/j.ijbiomac.2017.01.040

210. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012;43(3):630-636.

211. Hensley K, Carney J, Mattson M, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences. 1994;91(8). doi:10.1073/pnas.91.8.3270

212. Herrmann N, Rothenburg L, Black S, et al. Methylphenidate for the Treatment of Apathy in Alzheimer Disease. Journal of Clinical Psychopharmacology. 2008;28(3). doi:10.1097/jcp.0b013e318172b479

213. Hidese S, Ota M, Wakabayashi C, et al. Effects of chronicl-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiatrica. 2016;29(2). doi:10.1017/neu.2016.33

214. Higashiyama A, Htay H, Ozeki M, Juneja L, Kapoor M. Effects of l-theanine on attention and reaction time response. Journal of Functional Foods. 2011;3(3). doi:10.1016/j.jff.2011.03.009

215. Hill W. Comment on “Large-Scale cognitive GWAS Meta-analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets” by Lam et al. Published online December 1, 2017. doi:10.31234/osf.io/35jhz

216. Hoffmann P, Kench J, Vondracek A, et al. Interaction between Phosphatidylserine and the Phosphatidylserine Receptor Inhibits Immune Responses In Vivo. The Journal of Immunology. 2005;174(3). doi:10.4049/jimmunol.174.3.1393

217. Hofmeister E, Muilenburg J, Kogan L, Elrod S. Over-the-Counter Stimulant, Depressant, and Nootropic Use by Veterinary Students. Journal of Veterinary Medical Education. 2010;37(4). doi:10.3138/jvme.37.4.403

218. Hollingsworth N, Horley G, Mazhar M, et al. Tin(II) aminoalkoxides and heterobimetallic derivatives: the structures of Sn6(O)4(dmae)4, Sn6(O)4(OEt)4 and [Sn(dmae)2Cd(acac)2]2. Applied Organometallic Chemistry. 2006;20(10). doi:10.1002/aoc.1118

219. Holmes C, Wilkinson D, Dean C, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology. 2004;63(2). doi:10.1212/01.wnl.0000129990.32253.7b

220. Holmes J, Gathercole S, Dunning D. Adaptive training leads to sustained enhancement of poor working memory in children. Developmental Science. 2009;12(4). doi:10.1111/j.1467-7687.2009.00848.x

221. Hoogevest P, Wendel A. The use of natural and synthetic phospholipids as pharmaceutical excipients. European Journal of Lipid Science and Technology. 2014;116(9). doi:10.1002/ejlt.201400219

222. Howard R, Juszczak E, Ballard C, et al. Donepezil for the Treatment of Agitation in Alzheimer's Disease. New England Journal of Medicine. 2007;357(14). doi:10.1056/nejmoa066583

223. Howard R, McShane R, Lindesay J, et al. Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease. New England Journal of Medicine. 2012;366(10). doi:10.1056/nejmoa1106668

224. Hsieh C, Niemi E, Wang S, et al. CCR2 Deficiency Impairs Macrophage Infiltration and Improves Cognitive Function after Traumatic Brain Injury. Journal of Neurotrauma. 2014;31(20). doi:10.1089/neu.2013.3252

225. Hu S, Shi J, Xiong W, Li W, Fang L, Feng H. Oxiracetam or fastigial nucleus stimulation reduces cognitive injury at high altitude. Brain and Behavior. 2017;7(10). doi:10.1002/brb3.762

226. Huang L, Shang E, Fan W, et al. S-oxiracetam protect against ischemic stroke via alleviating blood brain barrier dysfunction in rats. European Journal of Pharmaceutical Sciences. 2017;109. doi:10.1016/j.ejps.2017.07.029

227. Huang Y, Mucke L. Alzheimer Mechanisms and Therapeutic Strategies. Cell. 2012;148(6). doi:10.1016/j.cell.2012.02.040

228. Huang Y, Huang X, Zhang L, et al. Magnesium boosts the memory restorative effect of environmental enrichment in Alzheimer's disease mice. CNS Neuroscience &; Therapeutics. 2017;24(1). doi:10.1111/cns.12775

229. Hunt A, Minett G, Gibson O, Kerr G, Stewart I. Could Heat Therapy Be an Effective Treatment for Alzheimer’s and Parkinson’s Diseases? A Narrative Review. Frontiers in Physiology. 2020;10. doi:10.3389/fphys.2019.01556

230. Hurtado O, Cardenas A, Pradillo J, et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiology of Disease. 2007;26(1). doi:10.1016/j.nbd.2006.12.005

231. Hurtado O, Pradillo J, Fernandez-Lopez D, et al. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Neurobiology of Disease. 2008;29(1). doi:10.1016/j.nbd.2007.08.004

232. Hurtado O, Hernandez-Jimenez M, Zarruk J, et al. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke. Journal of Neurochemistry. 2013;126(6). doi:10.1111/jnc.12269

233. Iasnetsov VV, Voronina TA. [Antihypoxic and antiamnesic effects of mexidol and semax]. Eksp Klin Farmakol. 2010;73(4):2-7.

234. Ilcol Y, Yilmaz Z, Cansev M, Ulus I. CHOLINE OR CDP-CHOLINE ALTERS SERUM LIPID RESPONSES TO ENDOTOXIN IN DOGS AND RATS: INVOLVEMENT OF THE PERIPHERAL NICOTINIC ACETYLCHOLINE RECEPTORS. Shock. 2009;32(3). doi:10.1097/shk.0b013e3181971b02

235. Jaganathan S, John A, Vellayappan M, Balaji A, Mohandas H, Subramanian A. Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery. International Journal of Nanomedicine. Published online July 1, 2015. doi:10.2147/ijn.s83777

236. Janarny G, Ranaweera K, Gunathilake K. Modeling and optimization of polyphenol extraction from the petals of iClitorea ternatea/i using response surface methodology. JSFA reports. 2022;2(8). doi:10.1002/jsf2.72

237. Janicki M, Dalton A, Henderson C, Davidson P. Mortality and morbidity among older adults with intellectual disability: health services considerations. Disability and Rehabilitation. 1999;21(5-6). doi:10.1080/096382899297710

238. Javan A, Framarzi S, Abedi A, Nattaj F. Effectiveness of Rhythmic Play on the Attention and Memory Functioning in Children with Mild Intellectual Disability (MID). International Letters of Social and Humanistic Sciences. 2013;17. doi:10.18052/www.scipress.com/ilshs.17.9

239. Jevtovic-Todorovic V, Hartman R, Izumi Y, et al. Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits. The Journal of Neuroscience. 2003;23(3). doi:10.1523/jneurosci.23-03-00876.2003

240. Jia L, Wang C, Wu Y, et al. Production of l-α-Glycerylphosphorylcholine from Oil Refining Waste Using a Novel Cold-Active Phospholipase B from iBacillus velezensis/i. ACS Sustainable Chemistry &; Engineering. 2021;9(39). doi:10.1021/acssuschemeng.1c04767

241. Jiao Y, Ma S, Li J, et al. N-Acetyl Cysteine (NAC)-Directed Detoxification of Methacryloxylethyl Cetyl Ammonium Chloride (DMAE-CB). PLOS ONE. 2015;10(8). doi:10.1371/journal.pone.0135815

242. JOHNSON J, KOTERMANSKI S. Mechanism of action of memantine. Current Opinion in Pharmacology. 2006;6(1). doi:10.1016/j.coph.2005.09.007

243. Johnson J, Head E, Kim R, Starr A, Cotman C. Clinical and Pathological Evidence for a Frontal Variant of Alzheimer Disease. Archives of Neurology. 1999;56(10). doi:10.1001/archneur.56.10.1233

244. Jones K, Puccio A, Harshman K, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurgical Focus. 2008;25(4). doi:10.3171/foc.2008.25.10.e3

245. Joshi H, Parle M. Zingiber officinale: evaulation of its Nootropic effect in mice. African Journal of Traditional, Complementary and Alternative Medicines. 2005;3(1). doi:10.4314/ajtcam.v3i1.31140

246. Ka{\v{z}}oka H, Koli{\v{s}}kina O, Veinberg G, Vorona M. Separation of piracetam derivatives on polysaccharide-based chiral stationary phases. Journal of Chromatography A. 2013;1281. doi:10.1016/j.chroma.2013.01.057

247. Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology. 2017;2017. doi:10.1155/2017/5091027

248. Kavirajan H. Memantine: a comprehensive review of safety and efficacy. Expert Opinion on Drug Safety. 2008;8(1). doi:10.1517/14740330802528420

249. Kawamura T, Okubo T, Sato K, et al. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition. 2012;28(11-12). doi:10.1016/j.nut.2012.02.011

250. Kay J, Koivusalo M, Ma X, Wohland T, Grinstein S. Phosphatidylserine dynamics in cellular membranes. Molecular Biology of the Cell. 2012;23(11). doi:10.1091/mbc.e11-11-0936

251. Kensinger E, Corkin S. Memory enhancement for emotional words: Are emotional words more vividly remembered than neutral words? Memory &; Cognition. 2003;31(8). doi:10.3758/bf03195800

252. Kensinger E, Corkin S. Two routes to emotional memory: Distinct neural processes for valence and arousal. Proceedings of the National Academy of Sciences. 2004;101(9). doi:10.1073/pnas.0306408101

253. Kerr S, Lawrence M, Darbyshire C, Middleton A, Fitzsimmons L. Tobacco and alcohol-related interventions for people with mild/moderate intellectual disabilities: a systematic review of the literature. Journal of Intellectual Disability Research. 2012;57(5). doi:10.1111/j.1365-2788.2012.01543.x

254. Kesmati M, Notarki Z, Issapareh N, Torabi M. Comparison the Effect of Zinc Oxide and Magnesium Oxide Nano Particles on Long Term Memory in Adult Male Mice. Zahedan Journal of Research in Medical Sciences. 2016;18(9). doi:10.17795/zjrms-3473

255. Keuck L. The twenty-first book review of The Alzheimer Conundrum. BioSocieties. 2017;12(1). doi:10.1057/s41292-017-0040-9

256. Khabirov F, Khaibullin T, Granatov E, Akhmetova G, Akhmetzyanov N. Comparison of the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2020;120(12). doi:10.17116/jnevro202012012211

257. Khare P, Chaudhary S, Singh L, Yadav G, Verma S. Evaluation of Nootropic activity of Cressa cretica in scopola-mine- induced memory impairment in mice. International Journal of Pharmacology and Toxicology. 2014;2(2). doi:10.14419/ijpt.v2i2.2004

258. Kim HY, Huang B, Spector A. Phosphatidylserine in the brain: Metabolism and function. Progress in Lipid Research. 2014;56. doi:10.1016/j.plipres.2014.06.002

259. Kim J, Song Y, Lee S, et al. Enzymatic preparation of food-grade l -α-glycerylphosphorylcholine from soy phosphatidylcholine or fractionated soy lecithin. Biotechnology Progress. 2019;36(1). doi:10.1002/btpr.2910

260. Kimura K, Ozeki M, Juneja L, Ohira H. l-Theanine reduces psychological and physiological stress responses. Biological Psychology. 2007;74(1). doi:10.1016/j.biopsycho.2006.06.006

261. KING C, RODGER J, BARTLETT C, ESMAILI T, DUNLOP S, BEAZLEY L. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Experimental Neurology. 2007;205(1). doi:10.1016/j.expneurol.2007.01.017

262. Kinzler K, Shutts K. Memory for “mean” over “nice”: The influence of threat on children’s face memory. Cognition. 2008;107(2). doi:10.1016/j.cognition.2007.09.005

263. Kitano Y, Komiyama C, Makino M, et al. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. Brain Research. 2005;1057(1-2). doi:10.1016/j.brainres.2005.07.052

264. Klepikova A. Curing Disability in Contemporary Russia: Rehabilitation Practices and the Placebo Effect. Ethnologia Polona. 2019;40. doi:10.23858/ethp40.2019.004

265. Koliaki C, Messini C, Tsolaki M. Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study\ast. CNS Neuroscience &; Therapeutics. 2011;18(4). doi:10.1111/j.1755-5949.2010.00244.x

266. Kolik L, Nadorova A, Kozlovskaya M. Efficacy of Peptide Anxiolytic Selank during Modeling of Withdrawal Syndrome in Rats with Stable Alcoholic Motivation. Bulletin of Experimental Biology and Medicine. 2014;157(1). doi:10.1007/s10517-014-2490-4

267. Kolomin T, Agapova T, Agniullin Ya, et al. Changes in the Transcription Profile of the Hippocampus in Response to Administration of the Tuftsin Analog Selank. Neuroscience and Behavioral Physiology. 2014;44(8). doi:10.1007/s11055-014-9992-4

268. Kolomin T, Morozova M, Volkova A, et al. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action. Molecular Immunology. 2014;58(1). doi:10.1016/j.molimm.2013.11.002

269. Kong LZ, Zhang RL, Hu SH, Lai JB. Military traumatic brain injury: a challenge straddling neurology and psychiatry. Military Medical Research. 2022;9(1). doi:10.1186/s40779-021-00363-y

270. Koo J, MacEwan M, Kang SK, et al. Wireless bioresorbable electronic system enables sustained nonpharmacological neuroregenerative therapy. Nature Medicine. 2018;24(12). doi:10.1038/s41591-018-0196-2

271. Kornhuber J, Kennepohl E, Bleich S, et al. Memantine Pharmacotherapy. Clinical Pharmacokinetics. 2007;46(7). doi:10.2165/00003088-200746070-00005

272. Koroleva S, Mjasoedov N. Physiological Effects of Selank and Its Fragments. Biology Bulletin. 2019;46(4). doi:10.1134/s1062359019040071

273. Koroleva S, Myasoedov N. Semax as a Universal Drug for Therapy and Research. Biology Bulletin. 2018;45(6). doi:10.1134/s1062359018060055

274. Kovalev G, Kondrakhin E, Salimov R. Behavioral and neuroreceptor differences in C57BL/6 and BALB/c mice. Neurochemical Journal. 2013;7(2). doi:10.1134/s1819712413020049

275. Kovalev G, Sukhorukova N, Kondrakhin E, Vasil’eva E, Salimov R. Influence of Piracetam on Brain Receptor Systems in CD-1 Mice with Different Attention Stability Phenotypes. Pharmaceutical Chemistry Journal. 2021;55(8). doi:10.1007/s11094-021-02489-8

276. Kovalev G, Vorob{'}ev V, Akhmetova E. NMDA component in the effects of piracetam and new nootropic peptide GVS-111 on the neocortical and hippocampal EEG in conscious rats. Bulletin of Experimental Biology and Medicine. 1999;128(2). doi:10.1007/bf02433825

277. Krahn G, Hammond L, Turner A. A cascade of disparities: Health and health care access for people with intellectual disabilities. Mental Retardation and Developmental Disabilities Research Reviews. 2006;12(1). doi:10.1002/mrdd.20098

278. Kramer A, Hahn S, Cohen N, et al. Ageing, fitness and neurocognitive function. Nature. 1999;400(6743). doi:10.1038/22682

279. Krupp L, Christodoulou C, Melville P, Scherl W, MacAllister W, Elkins L. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology. 2004;63(9). doi:10.1212/01.wnl.0000142989.09633.5a

280. Krylov V, Luk{'}ianchikov V. Cerebral revascularization for the treatment of patients with acute ischemic stroke. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2014;114(12. Vyp. 2). doi:10.17116/jnevro201411412246-52

281. Kryzhanovskii S, Salimov R, Lagunin A, Filimonov D, Gloriozova T, Poroikov V. Nootropic action of some antihypertensive drugs: computer predicting and experimental testing. Pharmaceutical Chemistry Journal. 2012;45(10). doi:10.1007/s11094-012-0689-0

282. Kumral A, Uysal N, Tugyan K, et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behavioural Brain Research. 2004;153(1). doi:10.1016/j.bbr.2003.11.002

283. Kurkin D, Morkovin E, Kalatanova A, et al. Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2021;121(7). doi:10.17116/jnevro202112107184

284. Kurkin D, Bakulin D, Morkovin E, et al. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PLOS ONE. 2021;16(7). doi:10.1371/journal.pone.0254493

285. Lopez-Valdes H, Clarkson A, Ao Y, et al. Memantine Enhances Recovery From Stroke. Stroke. 2014;45(7). doi:10.1161/strokeaha.113.004476

286. Ladurner G, Kalvach P, Moessler H. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Journal of neural transmission. 2005;112(3):415-428.

287. Lanct{\^{o}}t K, Rajaram R, Herrmann N. Review: Therapy for Alzheimer's disease: how effective are current treatments? Therapeutic Advances in Neurological Disorders. 2009;2(3). doi:10.1177/1756285609102724

288. Lardner A. Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders. Nutritional Neuroscience. 2013;17(4). doi:10.1179/1476830513y.0000000079

289. Lawrence Y, Li X, Naqa I, et al. Radiation Dose-Volume Effects in the Brain. International Journal of Radiation Oncology\astBiology\astPhysics. 2010;76(3). doi:10.1016/j.ijrobp.2009.02.091

290. Lebedeva I, Panikratova Ya, Sokolov O, et al. Effects of Semax on the Default Mode Network of the Brain. Bulletin of Experimental Biology and Medicine. 2018;165(5). doi:10.1007/s10517-018-4234-3

291. Lee CH, Koo HW, Han S, Choi CY, Sohn MJ, Lee CH. Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis. Journal of Neurosurgery. 2019;130(6). doi:10.3171/2018.4.jns1891

292. Lee G, Choi S, Chang J, et al. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Network Open. 2021;4(11). doi:10.1001/jamanetworkopen.2021.36008

293. Lee J, Hur J, Moon H, et al. Nonconvulsive Seizures of Traumatic Brain Injury Patients. Korean Journal of Neurotrauma. 2013;9(2). doi:10.13004/kjnt.2013.9.2.64

294. Lee P, Nokes L, Smith P. No Effect of Intravenous Actovegin® on Peak Aerobic Capacity. International Journal of Sports Medicine. 2012;33(04). doi:10.1055/s-0031-1291322

295. Lee P, Rattenberry A, Connelly S, Nokes L. Our Experience on Actovegin, is it Cutting Edge? International Journal of Sports Medicine. 2011;32(04). doi:10.1055/s-0030-1269862

296. Lee P, Kwan A, Nokes L. Actovegin® - Cutting-edge Sports Medicine or “Voodoo” Remedy? Current Sports Medicine Reports. 2011;10(4). doi:10.1249/jsr.0b013e318223cd8a

297. Lee S, Ryu S, Turk A, et al. Characterization of α-glucosidase inhibitory constituents of the fruiting body of lion's mane mushroom (Hericium erinaceus). Journal of Ethnopharmacology. 2020;262. doi:10.1016/j.jep.2020.113197

298. Lee S, Choi B, Kim J, et al. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment. Brain Research. 2017;1654. doi:10.1016/j.brainres.2016.10.011

299. Lemos B, Medina-Vera I, Blesso C, Fernandez M. Intake of 3 Eggs per Day When Compared to a Choline Bitartrate Supplement, Downregulates Cholesterol Synthesis without Changing the LDL/HDL Ratio. Nutrients. 2018;10(2). doi:10.3390/nu10020258

300. Lemos B, Medina-Vera I, Malysheva O, Caudill M, Fernandez M. Effects of Egg Consumption and Choline Supplementation on Plasma Choline and Trimethylamine-N-Oxide in a Young Population. Journal of the American College of Nutrition. 2018;37(8). doi:10.1080/07315724.2018.1466213

301. Leng F, Robeyns K, Leyssens T, Shemchuk O. Combining Racetams with a Sweetener through Complexation. Crystal Growth &; Design. 2022;22(5). doi:10.1021/acs.cgd.1c01462

302. Leventis P, Grinstein S. The Distribution and Function of Phosphatidylserine in Cellular Membranes. Annual Review of Biophysics. 2010;39(1). doi:10.1146/annurev.biophys.093008.131234

303. Levey A 167em}}I. Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer\hspace0.167emdisease. Proceedings of the National Academy of Sciences. 1996;93(24). doi:10.1073/pnas.93.24.13541

304. Li F, Chen J, Chai Z, et al. Effects of a dental adhesive incorporating antibacterial monomer on the growth, adherence and membrane integrity of Streptococcus mutans. Journal of Dentistry. 2009;37(4). doi:10.1016/j.jdent.2008.12.004

305. Li K, Du S, Wu S, et al. Determination and correlation of solubility and solution thermodynamics of oxiracetam in three (alcohol + water) binary solvents. The Journal of Chemical Thermodynamics. 2016;96. doi:10.1016/j.jct.2015.11.007

306. li W, Liu H, Jiang H, et al. (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. Scientific Reports. 2017;7(1). doi:10.1038/s41598-017-10283-4

307. Li X, Cui J, Yu Y, et al. Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce \upbeta-Amyloid Production and Improve Cognitive Impairments. PLOS ONE. 2016;11(3). doi:10.1371/journal.pone.0151147

308. Li Y, Wang J, Cai J. Aniracetam restores the effects of amyloid-\upbeta protein or ageing on membrane fluidity and intracellular calcium concentration in mice synaptosomes. Journal of Neural Transmission. 2007;114(11). doi:10.1007/s00702-007-0760-2

309. Li Y, Hu D, Sun Y. Content Determination of Aniracetam in Aniracetam Inclusion Complex by HPLC. Artificial Cells, Blood Substitutes, and Biotechnology. 2009;37(3). doi:10.1080/10731190902908387

310. Ligt J, Willemsen M, Bon B, et al. Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability. New England Journal of Medicine. 2012;367(20). doi:10.1056/nejmoa1206524

311. Lin H, Lee ReggieH, Lee MichelleH, et al. Cerebral ischemia and neuroregeneration. Neural Regeneration Research. 2018;13(3). doi:10.4103/1673-5374.228711

312. Lin J, Wu J, Lee P. Utilization of inpatient care and its determinants among persons with intellectual disabilities in day care centres in Taiwan. Journal of Intellectual Disability Research. 2004;48(7). doi:10.1111/j.1365-2788.2003.00572.x

313. Lindvall O, Wahlberg L. Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Experimental Neurology. 2008;209(1). doi:10.1016/j.expneurol.2007.08.019

314. Lippelt D, Kint S, Herk K, Naber M. No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults. PLOS ONE. 2016;11(6). doi:10.1371/journal.pone.0157714

315. Liptzin B, Laki A, Garb J, Fingeroth R, Krushell R. Donepezil in the Prevention and Treatment of Post-Surgical Delirium. The American Journal of Geriatric Psychiatry. 2005;13(12). doi:10.1097/00019442-200512000-00010

316. Liu C, Cheng Y, Guo Y, Qian H. Magnesium-L-threonate alleviate colonic inflammation and memory impairment in chronic-plus-binge alcohol feeding mice. Brain Research Bulletin. 2021;174. doi:10.1016/j.brainresbull.2021.06.009

317. Liu Prof. Magnesium L-threonate Prevents and Restores Memory Deficits Associated with Neuropathic Pain by Inhibition of TNF-α. Pain Physician. 2013;5$\mathsemicolon$16(5$\mathsemicolon$9). doi:10.36076/ppj.2013/16/e563

318. Liu R, Liu I, Bi X, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proceedings of the National Academy of Sciences. 2003;100(14). doi:10.1073/pnas.1332809100

319. Liu Z, Hu M, Lu P, et al. Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus. Neuroscience Letters. 2017;651. doi:10.1016/j.neulet.2017.04.022

320. Loomis L. Abstract Harmonic Analysis. vol. 1, Structure of Topological Groups, Integration Theory, and Group Representations. Edwin Hewitt and Kenneth A. Ross. Springer, Berlin; Academic Press, New York, 1963. viii + 519 pp. Illus. 19. Science. 1964;143(3607). doi:10.1126/science.143.3607.673

321. Lu D, Mahmood A, Qu C, Hong X, Kaplan D, Chopp M. COLLAGEN SCAFFOLDS POPULATED WITH HUMAN MARROW STROMAL CELLS REDUCE LESION VOLUME AND IMPROVE FUNCTIONAL OUTCOME AFTER TRAUMATIC BRAIN INJURY. Neurosurgery. 2007;61(3). doi:10.1227/01.neu.0000290908.38438.b2

322. Lu D, Qu C, Goussev A, et al. Statins Increase Neurogenesis in the Dentate Gyrus, Reduce Delayed Neuronal Death in the Hippocampal CA3 Region, and Improve Spatial Learning in Rat after Traumatic Brain Injury. Journal of Neurotrauma. 2007;24(7). doi:10.1089/neu.2007.0288

323. Lu Y, Zhang A, Wang X, Hao N, Chen K, Ouyang P. Surfactant enhancedl-α-glycerylphosphorylcholine production from phosphatidylcholine using phospholipase Asub1/subin the aqueous phase. Biocatalysis and Biotransformation. 2019;37(5). doi:10.1080/10242422.2019.1568413

324. Lythgoe MP, Jenei K, Prasad V. Regulatory decisions diverge over aducanumab for Alzheimer’s disease. bmj. 2022;376.

325. Maciuk A, Bouchet MJ, Mazars G, Um B, Anton R. Nootropic (medhya) plants from ayurvedic pharmacopoeia. Published online 2002. doi:10.4000/books.irdeditions.7273

326. Mahase E. FDA approves controversial Alzheimer’s drug despite uncertainty over effectiveness. Published online 2021.

327. Mahncke H, Connor B, Appelman J, et al. Memory enhancement in healthy older adults using a brain plasticity-based training program: A randomized, controlled study. Proceedings of the National Academy of Sciences. 2006;103(33). doi:10.1073/pnas.0605194103

328. Makara N, Gabdrakhmanova S, Sapozhnikova T, et al. New (−)−Cytisine Derivatives with Nootropic Activity. Pharmaceutical Chemistry Journal V 49. 2015;(5):301-303.

329. Malik M, Tlusto{\v{s}} P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. 2022;14(16). doi:10.3390/nu14163367

330. Malanga G, Aguiar M, Martinez H, Puntarulo S. New Insights on Dimethylaminoethanol (DMAE) Features as a Free Radical Scavenger. Drug Metabolism Letters. 2012;6(1). doi:10.2174/187231212800229282

331. Mali A, Hivrale M, Bandawane D, Chaudhari P. STUDY OF ANTI-INFLAMMATORY ACTIVITY OF CASSIA AURICULATA LINN. LEAVES IN WISTAR RATS. INDIAN DRUGS. 2012;49(11). doi:10.53879/id.49.11.p0044

332. Malik R, Sangwan A, Saihgal R, Jindal D, Piplani P. Towards Better Brain Management: Nootropics. Current Medicinal Chemistry. 2007;14(2). doi:10.2174/092986707779313408

333. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database of Systematic Reviews. Published online January 1, 2004. doi:10.1002/14651858.cd004395.pub2

334. Malykh A, Sadaie M. Piracetam and Piracetam-Like Drugs. Drugs. 2010;70(3). doi:10.2165/11319230-000000000-00000

335. Mamdouh S, Aboushousha T, Abdelraouf A, Hamdy H, Seleem M, Hassan H. Molecular Noninvasive Diagnosis of Hepatocellular Carcinoma Using Microsatellite Instability. Asian Pacific Journal of Cancer Prevention. 2021;22(10). doi:10.31557/apjcp.2021.22.10.3337

336. Marcinkowska A, Mankowska N, Kot J, Winklewski P. Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review. Neuropsychology Review. 2021;32(1). doi:10.1007/s11065-021-09500-9

337. Marcus L, Soileau J, Judge L, Bellar D. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. Journal of the International Society of Sports Nutrition. 2017;14(1). doi:10.1186/s12970-017-0196-5

338. Mari{\~{n}}o G, Kroemer G. Mechanisms of apoptotic phosphatidylserine exposure. Cell Research. 2013;23(11). doi:10.1038/cr.2013.115

339. Martini E, Salvicchi A, Ghelardini C, et al. Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. Bioorganic &; Medicinal Chemistry. 2009;17(21). doi:10.1016/j.bmc.2009.08.055

340. Martino M, Guandalini L, Mannelli L, et al. Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents. Bioorganic &; Medicinal Chemistry. 2017;25(6). doi:10.1016/j.bmc.2017.02.019

341. Marum R. Update on the use of memantine in Alzheimer&;rsquo;s disease. Neuropsychiatric Disease and Treatment. Published online March 1, 2009. doi:10.2147/ndt.s4048

342. Mashin V, Belova L, Chaplanova O, Khusnullina A, Manasyan A. An Open Clinical Trial of Cortexin in Cerebral Ischemia. Neuroscience and Behavioral Physiology. 2016;46(4). doi:10.1007/s11055-016-0247-4

343. Masliah E, Díez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barc). 2012;48 Suppl A:3-24. doi:10.1358/dot.2012.48(suppl.a).1739716

344. Masliah E, Armasolo F, Veinbergs I, Mallory M, Samuel W. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacology Biochemistry and Behavior. 1999;62(2):239-245.

345. Matheis R, Schultheis M, Tiersky L, DeLuca J, Millis S, Rizzo A. Is Learning and Memory Different in a Virtual Environment? The Clinical Neuropsychologist. 2007;21(1). doi:10.1080/13854040601100668

346. Matsunaga S, Kishi T, Iwata N. Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. PLOS ONE. 2015;10(4). doi:10.1371/journal.pone.0123289

347. Mayorga-Buiza M, Rivero-Garvia M, Marquez-Rivas J, Velasquez-Rodriguez C, Gomez-Gonzalez E. Letter to the Editor: Postoperative hyponatremia. Journal of Neurosurgery: Pediatrics. 2017;19(3). doi:10.3171/2016.7.peds16347

348. Mazenc F, Malisoff M. New prediction approach for stabilizing time-varying systems under time-varying input delay. Published online December 1, 2016. doi:10.1109/cdc.2016.7798746

349. McGaugh J. Memory--a Century of Consolidation. Science. 2000;287(5451). doi:10.1126/science.287.5451.248

350. McGeer P, McGeer E. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiology of Aging. 2007;28(5). doi:10.1016/j.neurobiolaging.2006.03.013

351. McKeage K. Memantine. CNS Drugs. 2009;23(10). doi:10.2165/11201020-000000000-00000

352. McKhann G. Changing Concepts of Alzheimer Disease. JAMA. 2011;305(23). doi:10.1001/jama.2011.810

353. McReynolds J, Donowho K, Abdi A, McGaugh J, Roozendaal B, McIntyre C. Memory-enhancing corticosterone treatment increases amygdala norepinephrine and Arc protein expression in hippocampal synaptic fractions. Neurobiology of Learning and Memory. 2010;93(3). doi:10.1016/j.nlm.2009.11.005

354. McShane R, Westby M, Roberts E, et al. Memantine for dementia. Cochrane Database of Systematic Reviews. Published online March 1, 2019. doi:10.1002/14651858.cd003154.pub6

355. Means B, Toyama Y, Murphy R, Baki M. The Effectiveness of Online and Blended Learning: A Meta-Analysis of the Empirical Literature. Teachers College Record: The Voice of Scholarship in Education. 2013;115(3). doi:10.1177/016146811311500307

356. Medvedev V, Tereshchenko O, Kost N, et al. Optimization of the treatment of anxiety disorders with selank. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2015;115(6). doi:10.17116/jnevro20151156133-40

357. Medvedeva E, Dmitrieva V, Limborska S, Myasoedov N, Dergunova L. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Molecular Genetics and Genomics. 2017;292(3). doi:10.1007/s00438-017-1297-1

358. Medvedeva E, Dmitrieva V, Povarova O, et al. Effect of Semax and its C-terminal Fragment Pro-Gly-Pro on the Expression of VEGF Family Genes and their Receptors in Experimental Focal Ischemia of the Rat Brain. Journal of Molecular Neuroscience. 2012;49(2). doi:10.1007/s12031-012-9853-y

359. Medvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014;15:228. doi:10.1186/1471-2164-15-228

360. Meilin S, Machicao F, Elmlinger M. Treatment with Actovegin improves spatial learning and memory in rats following transient forebrain ischaemia. Journal of Cellular and Molecular Medicine. 2014;18(8). doi:10.1111/jcmm.12297

361. Miller D, Papayannopoulos I, Styles J, et al. Peptide Compositions of the Cerebrovascular and Senile Plaque Core Amyloid Deposits of Alzheimer\primes Disease. Archives of Biochemistry and Biophysics. 1993;301(1). doi:10.1006/abbi.1993.1112

362. Mindham J, Espie C. Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID): development and psychometric properties of a new measure for use with people with mild intellectual disability. Journal of Intellectual Disability Research. 2003;47(1). doi:10.1046/j.1365-2788.2003.00457.x

363. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007;450(7168). doi:10.1038/nature06307

364. Mödinger Y, Schön C, Wilhelm M, Hals PA. Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoostTM Krill Oil or Choline Bitartrate in Healthy Volunteers. Nutrients. 2019;11(10). doi:10.3390/nu11102548

365. Mokhtar M, Ali R, Isa E. Silver Nanoparticles Loaded Activated Carbon Synthesis Using Clitorea Ternatea Extract for Crystal Violet Dye Removal. Journal of Research in Nanoscience and Nanotechnology. 2021;3(1). doi:10.37934/jrnn.3.1.2636

366. Monroe G, Frederix G, Savelberg S, et al. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. Genetics in Medicine. 2016;18(9). doi:10.1038/gim.2015.200

367. Mori E, Ikeda M, and K. Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial. Annals of Neurology. 2012;72(1). doi:10.1002/ana.23557

368. Moriguchi S, Tanaka T, Narahashi T, Fukunaga K. Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site ofiN/i-methyl-D-aspartate receptor. Hippocampus. 2013;23(10). doi:10.1002/hipo.22150

369. Moriguchi S, Tanaka T, Tagashira H, Narahashi T, Fukunaga K. Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice. Behavioural Brain Research. 2013;242. doi:10.1016/j.bbr.2012.12.054

370. Morris J. Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type. International Psychogeriatrics. 1997;9(S1). doi:10.1017/s1041610297004870

371. Morris J, Weintraub S, Chui H, et al. The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers. Alzheimer Disease &; Associated Disorders. 2006;20(4). doi:10.1097/01.wad.0000213865.09806.92

372. Morrison A, Chein J. Does working memory training work? The promise and challenges of enhancing cognition by training working memory. Psychonomic Bulletin &; Review. 2010;18(1). doi:10.3758/s13423-010-0034-0

373. Morton C, Aitchison A, Gehrig K, Ridgway N. A mechanism for suppression of the CDP-choline pathway during apoptosis. Journal of Lipid Research. 2013;54(12). doi:10.1194/jlr.m041434

374. Mota F, Nunes T, Borges {\^{A}}ngela, Silva A, Constant P. Extra\cc\~ao e quantifica\cc\~ao de antocianinas de flores Clitorea Ternatea desidratadas. Research, Society and Development. 2022;11(9). doi:10.33448/rsd-v11i9.32293

375. Moulder K, Snider B, Mills S, et al. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimer's Research &; Therapy. 2013;5(5). doi:10.1186/alzrt213

376. Mount C, Downton C. Alzheimer disease: progress or profit? Nature Medicine. 2006;12(7). doi:10.1038/nm0706-780

377. Mu W, Zhang T, Jiang B. An overview of biological production of L-theanine. Biotechnology Advances. 2015;33(3-4). doi:10.1016/j.biotechadv.2015.04.004

378. Mukhina A, Medvedeva O, Svishcheva M, et al. State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment. Bulletin of Experimental Biology and Medicine. 2019;167(2). doi:10.1007/s10517-019-04496-y

379. Mukhina A, Mishina E, Bobyntsev I, et al. Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bulletin of Experimental Biology and Medicine. 2020;169(2). doi:10.1007/s10517-020-04868-9

380. Müller W, Eckert G, Eckert A. Piracetam: Novelty in a Unique Mode of Action. Pharmacopsychiatry. 1999;32(S 1). doi:10.1055/s-2007-979230

381. Muresanu D, Rainer M, Moessler H. Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin®. In: Ageing and Dementia Current and Future Concepts. Springer; 2002:277-285.

382. Murphy M, LeVine H. Alzheimer’s Disease and the Amyloid-β Peptide. Journal of Alzheimer's Disease. 2010;19(1). doi:10.3233/jad-2010-1221

383. Mustafin R, Shilova I, Suslov N, Kuvacheva N, Amelchenko V. Nootropic Activity of Extracts from Wild and Cultivated Alfredia Cernua. Bulletin of Experimental Biology and Medicine. 2011;150(3). doi:10.1007/s10517-011-1135-0

384. Nabaee E, Kesmati M, Shahriari A, Khajehpour L, Torabi M. Cognitive and hippocampus biochemical changes following sleep deprivation in the adult male rat. Biomedicine &; Pharmacotherapy. 2018;104. doi:10.1016/j.biopha.2018.04.197

385. Nagata S, Suzuki J, Segawa K, Fujii T. Exposure of phosphatidylserine on the cell surface. Cell Death &; Differentiation. 2016;23(6). doi:10.1038/cdd.2016.7

386. Nakken H, Vlaskamp C. A Need for a Taxonomy for Profound Intellectual and Multiple Disabilities. Journal of Policy and Practice in Intellectual Disabilities. 2007;4(2). doi:10.1111/j.1741-1130.2007.00104.x

387. Näslund J, Schierhorn A, Hellman U, et al. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proceedings of the National Academy of Sciences. 1994;91(18). doi:10.1073/pnas.91.18.8378

388. Nathan P, Lu K, Gray M, Oliver C. The Neuropharmacology of L-Theanine(iN/i-Ethyl-L-Glutamine). Journal of Herbal Pharmacotherapy. 2006;6(2). doi:10.1080/j157v06n02_02

389. Nelson D. Cytochrome P450:\hspace0.167em Structure, Mechanism, and Biochemistry, 3rd ed Edited by Paul R. Ortiz de Montellano (University of California, San Francisco). Kluwer Academic/Plenum Publishers:\hspace0.167em New York. 2005. xx + 690 pp. 149.00. ISBN 0-306-48324-6. Journal of the American Chemical Society. 2005;127(34). doi:10.1021/ja041050x

390. Nemkova S. Speech disorders in children with cerebral palsy: diagnostics and correction. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2019;119(5). doi:10.17116/jnevro2019119051112

391. Neznamov GG, Teleshova ES. Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neuroscience and Behavioral Physiology. 2009;39(3):311. doi:10.1007/s11055-009-9128-4

392. Ngadni M, Akhtar M, Ismail I, et al. Clitorienolactones and Isoflavonoids of Clitorea ternatea Roots Alleviate Stress-Like Symptoms in a Reserpine-Induced Zebrafish Model. Molecules. 2021;26(14). doi:10.3390/molecules26144137

393. Nicoll J, Wilkinson D, Holmes C, Steart P, Markham H, Weller R. Neuropathology of human Alzheimer disease after immunization with amyloid-\upbeta peptide: a case report. Nature Medicine. 2003;9(4). doi:10.1038/nm840

394. Nkodo A. A Systematic Review of in-vivo Studies on Dietary Mushroom Supplementation for Cognitive Impairment (P14-021-19). Current Developments in Nutrition. 2019;3(Supplement{\_}1). doi:10.1093/cdn/nzz052.p14-021-19

395. Noor A, Whibley A, Marshall C, et al. Disruption at the iPTCHD1/i Locus on Xp22.11 in Autism Spectrum Disorder and Intellectual Disability. Science Translational Medicine. 2010;2(49). doi:10.1126/scitranslmed.3001267

396. Noorbala A, Akhondzadeh S, Davari-Ashtiani R, Amini-Nooshabadi H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. Journal of Clinical Pharmacy and Therapeutics. 1999;24(5). doi:10.1046/j.1365-2710.1999.00238.x

397. Nootarki Z, Kesmati M, Borujeni M. Effect of Magnesium Oxide Nanoparticles on Atropine-Induced Memory Impairment in Adult Male Mice. Avicenna Journal of Neuro Psych Physiology. 2015;2(4). doi:10.17795/ajnpp-36924

398. Nordhausen K. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Second Edition by Trevor Hastie, Robert Tibshirani, Jerome Friedman. International Statistical Review. 2009;77(3). doi:10.1111/j.1751-5823.2009.00095_18.x

399. Nurminen F, Rättö H, Arvio M, Teittinen A, Vesala H, Saastamoinen L. Medicine use in people with intellectual disabilities: a Finnish nationwide register study. Journal of Intellectual Disability Research. Published online November 1, 2022. doi:10.1111/jir.12988

400. Nutrition C for FS and A. Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling. FDA. Published online January 25, 2022. Accessed December 18, 2022. https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide-chapter-iv-nutrition-labeling

401. O’Neill B, Handler M, Tong S, Chapman K. Incidence of seizures on continuous EEG monitoring following traumatic brain injury in children. Journal of Neurosurgery: Pediatrics. 2015;16(2). doi:10.3171/2014.12.peds14263

402. Oguzturk H, Ciftci O, Cetin A, et al. Beneficial effects of hesperidin following cis-diamminedichloroplatinum-induced damage in heart of rats. Nigerian Journal of Clinical Practice. 2016;19(1). doi:10.4103/1119-3077.173707

403. Onaolapo A, Obelawo A, Onaolapo O. Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline. Current Aging Science. 2019;12(1). doi:10.2174/1874609812666190311160754

404. Ornelas I, Cini F, Wie{\ss}ner I, et al. Nootropic effects of LSD: Behavioral, molecular and computational evidence. Experimental Neurology. 2022;356. doi:10.1016/j.expneurol.2022.114148

405. Owen G, Parnell H, Bruin E, Rycroft J. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience. 2008;11(4). doi:10.1179/147683008x301513

406. Oyeneye A, Shen J, Shim Y, Tse T, Reaney M. Production of α-Glycerylphosphorylcholine and Other Compounds from Wheat Fermentation. ACS Omega. 2020;5(21). doi:10.1021/acsomega.0c01352

407. Özer D, Baran F, Aktop A, Nalbant S, A{\u{g}}lam{\i}{\c{s}} E, Hutzler Y. Effects of a Special Olympics Unified Sports soccer program on psycho-social attributes of youth with and without intellectual disability. Research in Developmental Disabilities. 2012;33(1). doi:10.1016/j.ridd.2011.09.011

408. Pandis D, Scarmeas N. Seizures in Alzheimer Disease: Clinical and Epidemiological Data. Epilepsy Currents. 2012;12(5). doi:10.5698/1535-7511-12.5.184

409. Panisset M, Gauthier S, Moessler H, Windisch M, and The Cerebrolysin Study Group. Cerebrolysin in Alzheimer’s disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent. J Neural Transm. 2002;109(7):1089-1104. doi:10.1007/s007020200092

410. Parker A, Byars A, Purpura M, Jäger R. The effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agility. Journal of the International Society of Sports Nutrition. 2015;12(sup1). doi:10.1186/1550-2783-12-s1-p41

411. Parsons C, Rammes G, Danysz W. Pharmacodynamics of Memantine: An Update. Current Neuropharmacology. 2008;6(1). doi:10.2174/157015908783769671

412. Paudel R, Raj K, Gupta Y, Singh S. Oxiracetam and Zinc Ameliorates Autism-Like Symptoms in Propionic Acid Model of Rats. Neurotoxicity Research. 2020;37(4). doi:10.1007/s12640-020-00169-1

413. Paul G, Anisimov S. The secretome of mesenchymal stem cells: Potential implications for~neuroregeneration. Biochimie. 2013;95(12). doi:10.1016/j.biochi.2013.07.013

414. Penry J, Manore M. Choline: An Important Micronutrient for Maximal Endurance-Exercise Performance? International Journal of Sport Nutrition and Exercise Metabolism. 2008;18(2). doi:10.1123/ijsnem.18.2.191

415. Percy M, Kruck T, Pogue A, Lukiw W. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. Journal of Inorganic Biochemistry. 2011;105(11). doi:10.1016/j.jinorgbio.2011.08.001

416. Perkins E, Moran J. Aging Adults With Intellectual Disabilities. JAMA. 2010;304(1). doi:10.1001/jama.2010.906

417. Peskind E, Potkin S, Pomara N, et al. Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial. The American Journal of Geriatric Psychiatry. 2006;14(8). doi:10.1097/01.jgp.0000224350.82719.83

418. Petersen R, Thomas R, Grundman M, et al. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. New England Journal of Medicine. 2005;352(23). doi:10.1056/nejmoa050151

419. Peterson J, Janz K, Lowe J. Physical activity among adults with intellectual disabilities living in community settings. Preventive Medicine. 2008;47(1). doi:10.1016/j.ypmed.2008.01.007

420. Petrenko Y, Vackova I, Kekulova K, et al. A Comparative Analysis of Multipotent Mesenchymal Stromal Cells derived from Different Sources, with a Focus on Neuroregenerative Potential. Scientific Reports. 2020;10(1). doi:10.1038/s41598-020-61167-z

421. Philippidis A. Green Light Raises Red Flags: FDA, some experts at odds over agency’s accelerated approval for Aduhelm, the Alzheimer’s disease drug from Biogen and Eisai. Clinical OMICs. 2021;8(4):12-14.

422. Phillips H, McDowell A, Mielby B, Tucker I, Colombo M. Aniracetam does not improve working memory in neurologically healthy pigeons. PLOS ONE. 2019;14(4). doi:10.1371/journal.pone.0215612

423. Pijl P, Chen L, Mulder T. Human disposition of L-theanine in tea or aqueous solution. Journal of Functional Foods. 2010;2(4). doi:10.1016/j.jff.2010.08.001

424. Pitkänen A, Kubova H. Antiepileptic drugs in neuroprotection. Expert Opinion on Pharmacotherapy. 2004;5(4). doi:10.1517/14656566.5.4.777

425. Pityk O, Seliverstova V. The case of successful treatment of gender identity disorder of childhood. European Psychiatry. 2017;41(S1). doi:10.1016/j.eurpsy.2017.01.480

426. Plangar I, Szabo E, T{\H{o}}kes T, et al. Radio-neuroprotective effect of L-alpha-glycerylphosphorylcholine (GPC) in an experimental rat model. Journal of Neuro-Oncology. 2014;119(2). doi:10.1007/s11060-014-1489-z

427. Pleijel H, Uddling J. Yield vs. Quality trade-offs for wheat in response to carbon dioxide and ozone. Global Change Biology. 2011;18(2). doi:10.1111/j.1365-2486.2011.2489.x

428. Plosker G, Lyseng-Williamson K. Memantine. PharmacoEconomics. 2005;23(2). doi:10.2165/00019053-200523020-00010

429. Popova E, Shavykin O, Neelov I, Leermakers F. Molecular dynamics simulation of lysine dendrimer and semax peptides interaction. Scientific and Technical Journal of Information Technologies, Mechanics and Optics. Published online July 1, 2016. doi:10.17586/2226-1494-2016-16-4-716-724

430. Popova E, Khamidova D, Neelov I, Komilov F. Lysine Dendrimers and Their Complexes with Therapeutic and Amyloid Peptides: Computer Simulation. Published online April 1, 2018. doi:10.5772/intechopen.71052

431. Popova E, Okrugin B, Neelov I. Molecular Dynamics Simulation of Interaction of Short Lysine Brush and Oppositely Charged Semax Peptides. Natural Science. 2016;08(12). doi:10.4236/ns.2016.812051

432. Porsteinsson A, Drye L, Pollock B, et al. Effect of Citalopram on Agitation in Alzheimer Disease. JAMA. 2014;311(7). doi:10.1001/jama.2014.93

433. Porter T. Media for Microeconomics. The Journal of Economic Education. 2009;40(4). doi:10.1080/00220480903280178

434. Prabowo U, Saraswati P. Effect of maltodextrin concentration and drying temperature on the characteristics of watermelon (Citrullus vulgaris S.) albedo instant drink enriched with telang flower (Clitorea ternatea) extract. Anjoro: International Journal of Agriculture and Business. 2021;2(2). doi:10.31605/anjoro.v2i2.1058

435. Prajapati P, Vaghela V, Rawtani D, Patel H, Kubavat J, Baraiya D. Azeotropic mixture used for development and validation of Lornoxicam in bulk and its tablet dosage form by spectrophotometric method. Journal of Pharmaceutical Analysis. 2012;2(4). doi:10.1016/j.jpha.2012.02.004

436. Prestes P. Development, physical-chemical stability and rheological behavior of silicones formulations containing Dimethylaminoethanol (DMAE). Journal of Applied Pharmaceutical Science. Published online February 1, 2013. doi:10.7324/japs.2013.30201

437. Prosser H, Bromley J. Interviewing People with Intellectual Disabilities. Published online March 1, 2012. doi:10.1002/9781118404898.ch6

438. Putilina M, Mutovina Z, Kurushina O, et al. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program. Neuroscience and Behavioral Physiology. 2022;52(6). doi:10.1007/s11055-022-01307-2

439. Rabasseda X, Mealy N. Brodimoprim: A specific dihydrofolate reductase inhibitor with high tissue penetration, long half-life and broad-spectrum antibacterial activity, suitable for oral administration. Drugs of Today. 1994;30(5). doi:10.1358/dot.1994.30.5.288834

440. Raj D, Masilamani N, Ganapathy D. Awareness on nootropic herbs among dental students Herbal nootropic agents. International Journal of Research in Pharmaceutical Sciences. 2020;11({SPL}3). doi:10.26452/ijrps.v11ispl3.3040

441. Rapley M. The Social Construction of Intellectual Disability. Published online June 1, 2004. doi:10.1017/cbo9780511489884

442. Rasch B, Born J. About Sleep’s Role in Memory. Physiological Reviews. 2013;93(2). doi:10.1152/physrev.00032.2012

443. Rashvand S, Mobasseri M, Tarighat-Esfanjani A. Effects of Choline and Magnesium Concurrent Supplementation on Coagulation and Lipid Profile in Patients with Type 2 Diabetes Mellitus: a Pilot Clinical Trial. Biological Trace Element Research. 2019;194(2). doi:10.1007/s12011-019-01802-7

444. Raves M, Harel M, Pang YP, Silman I, Kozikowski A, Sussman J. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nature Structural &; Molecular Biology. 1997;4(1). doi:10.1038/nsb0197-57

445. Ravindran S, Gopalakrishnan S, Kurian G. Beneficial effect of sodium thiosulfate extends beyond myocardial tissue in isoproterenol model of infarction: Implication for nootropic effects. Journal of Biochemical and Molecular Toxicology. 2020;34(12). doi:10.1002/jbt.22606

446. Rees L, Marshall S, Hartridge C, Mackie D, Weiser M. Cognitive interventions post acquired brain injury. Brain Injury. 2007;21(2). doi:10.1080/02699050701201813

447. Reichl FX, Högg C, Liu F, et al. Actovegin® reduces PMA-induced inflammation on human cells. European Journal of Applied Physiology. 2020;120(7). doi:10.1007/s00421-020-04398-2

448. Reichl FX, Holdt L, Teupser D, et al. Comprehensive Analytics of Actovegin® and Its Effect on Muscle Cells. International Journal of Sports Medicine. 2017;38(11). doi:10.1055/s-0043-115738

449. Rekis T, Be̅rzi{\c{n}}{\v{s}} A, Orola L, et al. Single Enantiomer’s Urge to Crystallize in Centrosymmetric Space Groups: Solid Solutions of Phenylpiracetam. Crystal Growth &; Design. 2017;17(3). doi:10.1021/acs.cgd.6b01867

450. Ressler K, Mayberg H. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nature Neuroscience. 2007;10(9). doi:10.1038/nn1944

451. Reuter-Lorenz P, Cappell K. Neurocognitive Aging and the Compensation Hypothesis. Current Directions in Psychological Science. 2008;17(3). doi:10.1111/j.1467-8721.2008.00570.x

452. Reutov V, Samosudova N, Filippova N, et al. Cortexin and combination of nitrite with cortexin decrease swelling and destruction of cerebellar neurons in hemorrhagic stroke. Doklady Biological Sciences. 2009;426(1). doi:10.1134/s0012496609030028

453. Reynolds C, Jefferson T, Volquardsen M, et al. Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy. F1000Research. 2017;6. doi:10.12688/f1000research.11023.2

454. Reynolds C, Jefferson T, Volquardsen M, et al. Study of oral aniracetam in C57BL/6J mice without pre-existing cognitive impairments. F1000Research. 2017;6. doi:10.12688/f1000research.11023.1

455. Rial D, Takahashi R, Morato G. Aniracetam and DNQX affect the acquisition of rapid tolerance to ethanol in mice. Pharmacology Biochemistry and Behavior. 2009;92(1). doi:10.1016/j.pbb.2008.10.006

456. Ricci S, Celani M, Cantisani T, Righetti E. Piracetam for acute ischaemic stroke. Published online April 1, 2006. doi:10.1002/14651858.cd000419.pub2

457. Richards S, Hendrie H. Diagnosis, Management, and Treatment of Alzheimer Disease. Archives of Internal Medicine. 1999;159(8). doi:10.1001/archinte.159.8.789

458. Robinson D, Keating G. Memantine. Drugs. 2006;66(11). doi:10.2165/00003495-200666110-00015

459. Rockenstein E, Mante M, Adame A, Crews L, Moessler H, Masliah E. Effects of Cerebrolysin^TM on neurogenesis in an APP transgenic model of Alzheimer’s disease. Acta neuropathologica. 2007;113(3):265-275.

460. Rockenstein E, Torrance M, Mante M, et al. Cerebrolysin decreases amyloid‐β production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer’s disease. Journal of neuroscience research. 2006;83(7):1252-1261.

461. Rodenberg R, Holden J. Cognition enhancing drugs (`nootropics’): time to include coaches and team executives in doping tests? British Journal of Sports Medicine. 2016;51(18). doi:10.1136/bjsports-2015-095474

462. Rodriguez M, Lippi S. Lion’s Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model. Behavioral Sciences. 2022;12(7). doi:10.3390/bs12070235

463. Röhrig U, Laio A, Tantalo N, Parrinello M, Petronzio R. Stability and Structure of Oligomers of the Alzheimer Peptide A\upbeta16-22: From the Dimer to the 32-Mer. Biophysical Journal. 2006;91(9). doi:10.1529/biophysj.106.088542

464. Rondal JA, Perera J. Perspectives of hybrid therapeutic strategies in intellectual disabilities and Down syndrome. Published online June 1, 2011. doi:10.1017/cbo9780511919299.018

465. Roozendaal B. Stress and Memory: Opposing Effects of Glucocorticoids on Memory Consolidation and Memory Retrieval,. Neurobiology of Learning and Memory. 2002;78(3). doi:10.1006/nlme.2002.4080

466. Roozendaal B, McEwen B, Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience. 2009;10(6). doi:10.1038/nrn2651

467. Rossi P, Cesaroni V, Brandalise F, et al. Dietary Supplementation of Lion’s Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), and Spatial Memory in Wild-Type Mice. International Journal of Medicinal Mushrooms. 2018;20(5). doi:10.1615/intjmedmushrooms.2018026241

468. Ruether E, Ritter R, Apecechea M, Freytag S, Gmeinbauer R, Windisch M. Sustained improvements in patients with dementia of Alzheimer’s type (DAT) 6 months after termination of Cerebrolysin therapy. Journal of neural transmission. 2000;107(7):815-829.

469. Ruether E, Alvarez XA, Rainer M, Moessler H. Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease:a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin®. In: Jellinger KA, Schmidt R, Windisch M, eds. Ageing and Dementia Current and Future Concepts. Journal of Neural Transmission. Supplementa. Springer Vienna; 2002:265-275.

470. Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4). doi:10.1016/j.phymed.2003.12.008

471. S. D. Analytic Geometry. By Frederick S. Nowlan. 3rd edition. Pp. 355. 2.75. 1946. (McGraw Hill). The Mathematical Gazette. 1946;30(290). doi:10.2307/3609121

472. S{\o}dal H, Storvig G, Tverdal C, Robinson H, Helseth E, Taub{\o}ll E. Early post-traumatic seizures in hospitalized patients with traumatic brain injury. Acta Neurologica Scandinavica. 2022;146(5). doi:10.1111/ane.13670

473. S{\o}nderg{\aa}rd S, Dela F, Helge J, Larsen S. Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle. European Journal of Sport Science. 2016;16(7). doi:10.1080/17461391.2015.1130750

474. Sakai K, Yamamoto A, Matsubara K, et al. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. Journal of Clinical Investigation. Published online December 1, 2011. doi:10.1172/jci59251

475. Samartgis J, Schachte L, Hazi A, Crowe S. Piracetam, an AMPAkine drug, facilitates memory consolidation in the day-old chick. Pharmacology Biochemistry and Behavior. 2012;103(2). doi:10.1016/j.pbb.2012.08.014

476. Samotrueva M, Yasenyavskaya A, Murtalieva V, et al. Experimental Substantiation of Application of Semax as a Modulator of Immune Reaction on the Model of “Social” Stress. Bulletin of Experimental Biology and Medicine. 2019;166(6). doi:10.1007/s10517-019-04434-y

477. Sanad M, Marzook E, El-Kawy O. Radiochemical and biological characterization of 99mTc-oxiracetam as a model for brain imaging. Radiochemistry. 2017;59(6). doi:10.1134/s1066362217060011x

478. Sanad M, Rizvi S, Farag A. Synthesis, characterization, and bioevaluation of sup99m/supTc nitrido-oxiracetam as a brain imaging model. Radiochimica Acta. 2021;109(6). doi:10.1515/ract-2021-0003

479. Sanad M, Sakr T, Abdel-Hamid W, Marzook E. In silico study and biological evaluation of 99mTc-tricabonyl oxiracetam as a selective imaging probe for AMPA receptors. Journal of Radioanalytical and Nuclear Chemistry. 2016;314(3). doi:10.1007/s10967-016-5120-y

480. Sanad M, Sallam Kh, Salama D. 99mTc-Oxiracetam as a Potential Agent for Diagnostic Imaging of Brain: Labeling, Characterization, and Biological Evaluation. Radiochemistry. 2018;60(1). doi:10.1134/s1066362218010101

481. Sanad M, Farag A, Husseiny D. Radioiodinated aniracetam, brain imaging, gamma camera, molecular modeling and docking. Egyptian Journal of Radiation Sciences and Applications. 2017;0(0). doi:10.21608/ejrsa.2017.1523.1017

482. Sani G, Serra G, Kotzalidis G, et al. The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias. CNS Drugs. 2012;26(8). doi:10.2165/11634390-000000000-00000

483. Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research. Best Practice &; Research Clinical Anaesthesiology. 2010;24(4). doi:10.1016/j.bpa.2010.10.005

484. Sastre A, Sherriff F, McShane R. Memantine for dementia. Published online July 1, 2005. doi:10.1002/14651858.cd003154.pub4

485. Scapicchio P. Revisiting choline alphoscerate profile: a new, perspective, role in dementia? International Journal of Neuroscience. 2013;123(7). doi:10.3109/00207454.2013.765870

486. Scheid L, Ellinger S, Alteheld B, et al. Kinetics of L-Theanine Uptake and Metabolism in Healthy Participants Are Comparable after Ingestion of L-Theanine via Capsules and Green Tea. The Journal of Nutrition. 2012;142(12). doi:10.3945/jn.112.166371

487. Scheuer K, Rostock A, Bartsch R, Müller W. Piracetam Improves Cognitive Performance by Restoring Neurochemical Deficits of the Aged Rat Brain. Pharmacopsychiatry. 1999;32(S 1). doi:10.1055/s-2007-979231

488. Schifano F, Catalani V, Sharif S, et al. Benefits and Harms of `Smart Drugs’ (Nootropics) in Healthy Individuals. Drugs. 2022;82(6). doi:10.1007/s40265-022-01701-7

489. Schmidt U, Brendemühl D, Schenk N. Kann das Nootropikum Piracetam das Fahrverhalten älterer Kraftfahrer beeinflussen? (Zwischenergebnisse einer kontrollierten Doppelblindstudie). Published online 1988. doi:10.1007/978-3-642-73811-1_15

490. Schneider L. Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease. Archives of Neurology. 2011;68(8). doi:10.1001/archneurol.2011.69

491. Schneider L. Alzheimer Disease Pharmacologic Treatment and Treatment Research. CONTINUUM: Lifelong Learning in Neurology. 2013;19(2). doi:10.1212/01.con.0000429180.60095.d0

492. Schutters K, Reutelingsperger C. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis. 2010;15(9). doi:10.1007/s10495-010-0503-y

493. Sciacca M, Naletova I, Giuffrida M, Attanasio F. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. ACS Chemical Neuroscience. 2022;13(4). doi:10.1021/acschemneuro.1c00707

494. Segawa K, Nagata S. An Apoptotic `Eat Me’ Signal: Phosphatidylserine Exposure. Trends in Cell Biology. 2015;25(11). doi:10.1016/j.tcb.2015.08.003

495. Seltzer B. Donepezil: a review. Expert Opinion on Drug Metabolism &; Toxicology. 2005;1(3). doi:10.1517/17425255.1.3.527

496. Seltzer B. Donepezil: an update. Expert Opinion on Pharmacotherapy. 2007;8(7). doi:10.1517/14656566.8.7.1011

497. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantification of soluble Alzheimer's \upbeta-peptide from biological fluids. Nature. 1992;359(6393). doi:10.1038/359325a0

498. Shabanov P, Lebedev A, Stetsenko V, Lavrov N, Markov S, Vojeikov I. Comparison of behavioral effects of cortexin and cerebrolysin injected into brain ventricles. Bulletin of Experimental Biology and Medicine. 2007;143(4). doi:10.1007/s10517-007-0150-7

499. Shahid M, Hamid M, Mazhar M, Akhtar J, Zeller M, Hunter A. Crystalline Cu-PbO ceramic composite thin films from Pb2(OAc)4(\upmu-O)3Cu6(dmae)4Cl4\cdotp(C7H8)\cdotp1.7(H2O). Inorganic Chemistry Communications. 2011;14(1). doi:10.1016/j.inoche.2010.11.017

500. Shao D, Yang Z, Zhou G. Aniracetam Solubility in Pure and Binary Solvents: Effect of Molecular Interaction and Analysis of Crystallized Products. Journal of Chemical &; Engineering Data. 2018;63(8). doi:10.1021/acs.jced.8b00023

501. Shariatgorji M, Nilsson A, Goodwin R, et al. Direct Targeted Quantitative Molecular Imaging of Neurotransmitters in Brain Tissue Sections. Neuron. 2014;84(4). doi:10.1016/j.neuron.2014.10.011

502. Sharma B, Kanwar S. Phosphatidylserine: A cancer cell targeting biomarker. Seminars in Cancer Biology. 2018;52. doi:10.1016/j.semcancer.2017.08.012

503. Sharma E, Joshi R, Gulati A. l-Theanine: An astounding sui generis integrant in tea. Food Chemistry. 2018;242. doi:10.1016/j.foodchem.2017.09.046

504. Shemchuk O, Song L, Tumanov N, et al. Chiral Resolution of iRS-/iOxiracetam upon Cocrystallization with Pharmaceutically Acceptable Inorganic Salts. Crystal Growth &; Design. 2020;20(4). doi:10.1021/acs.cgd.9b01725

505. Shilova I, Suslov N. Nootropic Effect of Meadowsweet (Filipendula vulgaris) Extracts. Bulletin of Experimental Biology and Medicine. 2015;158(5). doi:10.1007/s10517-015-2841-9

506. Shinozaki K, Yamaguchi-Shinozaki K. Gene Expression and Signal Transduction in Water-Stress Response. Plant Physiology. 1997;115(2). doi:10.1104/pp.115.2.327

507. Silva L, Mageste A, Paula B, Caires L, Hespanhol M, Ferreira G. Liquid-liquid equilibrium of aqueous two-phase systems formed by non-ionic surfactant (Triton X-165 or Triton X-305) and ionic liquid based on the choline cation (choline bitartrate or choline dihydrogen citrate). Journal of Molecular Liquids. 2020;318. doi:10.1016/j.molliq.2020.114030

508. Singh N, Hroudova J, Fi{\v{s}}ar Z. In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity. Molecular Neurobiology. 2016;54(8). doi:10.1007/s12035-016-0121-y

509. Skvortsova V, Stakhovskaia L, Gubskiĭ L, Shamalov N, Tikhonova I, Smychkov A. A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2004;(Suppl 11):51-55.

510. Skwarnicki T. Observation of J / \uppsi p Resonances Consistent With Pentaquark States. Published online November 1, 2016. doi:10.22323/1.245.0004

511. Slominsky P, Shadrina M, Kolomin T, et al. Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Doklady Biological Sciences. 2017;474(1). doi:10.1134/s0012496617030048

512. Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of Learning and Memory by Elevating Brain Magnesium. Neuron. 2010;65(2). doi:10.1016/j.neuron.2009.12.026

513. Slyusar O, Maximov I, Babaskina L, Lobuteva L. Ineffective Drugs: Cerebrolysin and Piracetam. Research Journal of Pharmacy and Technology. Published online May 1, 2021. doi:10.52711/0974-360x.2021.00466

514. Small G. Diagnosis and Treatment of Alzheimer Disease and Related Disorders. JAMA. 1997;278(16). doi:10.1001/jama.1997.03550160083043

515. Smolders L, Wit N, Balvers M, Obeid R, Vissers M, Esser D. Natural Choline from Egg Yolk Phospholipids Is More Efficiently Absorbed Compared with Choline Bitartrate; Outcomes of A Randomized Trial in Healthy Adults. Nutrients. 2019;11(11). doi:10.3390/nu11112758

516. Snowdon D. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA: The Journal of the American Medical Association. 1997;277(10). doi:10.1001/jama.277.10.813

517. Soares M, King S, Thorpe P. Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nature Medicine. 2008;14(12). doi:10.1038/nm.1885

518. Solomon B, Koppel R, Hanan E, Katzav T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proceedings of the National Academy of Sciences. 1996;93(1). doi:10.1073/pnas.93.1.452

519. Song MK, Seon HJ, Kim IG, Han JY, Choi IS, Lee SG. The Effect of Combined Therapy of Exercise and Nootropic Agent on Cognitive Function in Focal Cerebral Infarction Rat Model. Annals of Rehabilitation Medicine. 2012;36(3). doi:10.5535/arm.2012.36.3.303

520. Song Y, Roh S, Hwang J, Chung MY, Kim IH, Kim B. Immobilized Phospholipase Asub1/sub-Catalyzed Preparation of l-α-Glycerylphosphorylcholine from Phosphatidylcholine. Journal of Agricultural and Food Chemistry. 2020;68(44). doi:10.1021/acs.jafc.0c06381

521. Spelman K, Sutherland E, Bagade A. Neurological Activity of Lion’s Mane (iHericium erinaceus/i). Journal of Restorative Medicine. 2017;6(1). doi:10.14200/jrm.2017.6.0108

522. Sreemantula S, Nammi S, Kolanukonda R, Koppula S, Boini K. Adaptogenic and nootropic activities of aqueous extract of Vitis vinifera (grape seed): an experimental study in rat model. BMC Complementary and Alternative Medicine. 2005;5(1). doi:10.1186/1472-6882-5-1

523. STACE C, KTISTAKIS N. Phosphatidic acid- and phosphatidylserine-binding proteins. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2006;1761(8). doi:10.1016/j.bbalip.2006.03.006

524. Steffen W, Rockström J, Richardson K, et al. Trajectories of the Earth System in the Anthropocene. Proceedings of the National Academy of Sciences. 2018;115(33). doi:10.1073/pnas.1810141115

525. Stepanichev M, Onufriev M, Peregud D, et al. The Effects of Cortexin on Free-Radical Oxidation and Inflammatory Processes in Rats with Normal and Accelerated Aging. Neurochemical Journal. 2018;12(2). doi:10.1134/s1819712418020113

526. Stough C, Downey L, Lloyd J, et al. Examining the nootropic effects of a special extract ofiBacopa monniera/ion human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytotherapy Research. 2008;22(12). doi:10.1002/ptr.2537

527. Strifler G, Tuboly E, Görbe A, Boros M, Pecz D, Hartmann P. Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine. PLOS ONE. 2016;11(11). doi:10.1371/journal.pone.0166682

528. Strittmatter W, Weisgraber K, Huang D, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proceedings of the National Academy of Sciences. 1993;90(17). doi:10.1073/pnas.90.17.8098

529. Sudarkina O, Filippenkov I, Stavchansky V, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. International Journal of Molecular Sciences. 2021;22(12). doi:10.3390/ijms22126179

530. Sugimoto H, Yamanish Y, Iimura Y, Kawakami Y. Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors. Current Medicinal Chemistry. 2000;7(3). doi:10.2174/0929867003375191

531. Suliman N, Taib C, Moklas M, Adenan M, Baharuldin M, Basir R. Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evidence-Based Complementary and Alternative Medicine. 2016;2016. doi:10.1155/2016/4391375

532. Sun Y, Xu B, Zhang Q. Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. Pakistan Journal of Medical Sciences. 2018;34(1). doi:10.12669/pjms.341.13395

533. Sushruta K, Spandana R, Satyanarayana S. Adaptogenic and nootropic activities of aqueous extract of Carum carvi Linn. (Caraway) fruit: An experimental study in Wistar rats. Planta Medica. 2009;75(09). doi:10.1055/s-0029-1234468

534. Szabo E, Plangar I, T{\H{o}}kes T, et al. l-Alpha Glycerylphosphorylcholine as a Potential Radioprotective Agent in Zebrafish Embryo Model. Zebrafish. 2016;13(6). doi:10.1089/zeb.2016.1269

535. T{\H{o}}kes T, Tuboly E, Varga G, et al. Protective effects of l-alpha-glycerylphosphorylcholine on ischaemia-reperfusion-induced inflammatory reactions. European Journal of Nutrition. 2014;54(1). doi:10.1007/s00394-014-0691-2

536. Tabb{\`{\i}} G, Magr{\`{\i}} A, Giuffrida A, et al. Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective ability against metal induced cell toxicity. Journal of Inorganic Biochemistry. 2015;142. doi:10.1016/j.jinorgbio.2014.09.008

537. Tadini K, Mercurio D, Campos P. Acetyl hexapeptide-3 in a cosmetic formulation acts on skin mechanical properties - clinical study. Brazilian Journal of Pharmaceutical Sciences. 2015;51(4). doi:10.1590/s1984-82502015000400016

538. Tamura Y, Takata K, Matsubara K, Kataoka Y. Alpha-Glycerylphosphorylcholine Increases Motivation in Healthy Volunteers: A Single-Blind, Randomized, Placebo-Controlled Human Study. Nutrients. 2021;13(6). doi:10.3390/nu13062091

539. Tang YP, Shimizu E, Dube G, et al. Genetic enhancement of learning and memory in mice. Nature. 1999;401(6748). doi:10.1038/43432

540. Tao Y, Wang Z, Xu H, et al. Moisture-powered memristor with interfacial oxygen migration for power-free reading of multiple memory states. Nano Energy. 2020;71. doi:10.1016/j.nanoen.2020.104628

541. Tariot P, Farlow M, Grossberg G, et al. Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil. JAMA. 2004;291(3). doi:10.1001/jama.291.3.317

542. Tavares A, Rosado A, Mar{\^{o}}co J, Calmeiro L, Serpa S. Determinants of the Intention to Use Performance-Enhancing Substances Among Portuguese Gym Users. Frontiers in Psychology. 2020;10. doi:10.3389/fpsyg.2019.02881

543. Teather L, Wurtman R. Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats. Learning &; Memory. 2005;12(1). doi:10.1101/lm.83905

544. Temerdashev A, Zorina M, Dmitrieva E, Azaryan A. A Study of the Metabolism of the New Nootropic Preparation Unifiram by Ultra-High Performance Liquid Chromatography-High-Resolution Mass Spectrometry. Journal of Analytical Chemistry. 2021;76(2). doi:10.1134/s1061934821020131

545. Teri L, Rabins P, Whitehouse P, et al. Management of Behavior Disturbance in Alzheimer Disease. Alzheimer Disease &; Associated Disorders. 1992;6(2). doi:10.1097/00002093-199206020-00003

546. Terzi E, Hölzemann G, Seelig J. Interaction of Alzheimer \upbeta-Amyloid Peptide(1-40) with Lipid Membranes. Biochemistry. 1997;36(48). doi:10.1021/bi971843e

547. Thapa R. Mental retardation among children with cerebral palsy as observed in Nepal with a small trial with nootropic (Modafinil). European Journal of Paediatric Neurology. 2017;21. doi:10.1016/j.ejpn.2017.04.1188

548. Thorley E, Kang I, D’Costa S, et al. Varsity Medical Ethics Debate 2015: should nootropic drugs be available under prescription on the NHS? Philosophy, Ethics, and Humanities in Medicine. 2016;11(1). doi:10.1186/s13010-016-0041-5

549. Titus D, Wilson N, Freund J, et al. Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor. Journal of Neuroscience. 2016;36(27). doi:10.1523/jneurosci.3212-15.2016

550. Tivay M, Tavakoli S, Sarkoohi P. Aducanumab (Aduhelm®️): A Comparison of Positive and Negative Aspects.

551. Tiwari V, Kuhad A, Bishnoi M, Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacology Biochemistry and Behavior. 2009;93(2). doi:10.1016/j.pbb.2009.05.009

552. Tjernberg L, Callaway D, Tjernberg A, et al. A Molecular Model of Alzheimer Amyloid \upbeta-Peptide Fibril Formation. Journal of Biological Chemistry. 1999;274(18). doi:10.1074/jbc.274.18.12619

553. Tomassoni D, Avola R, Mignini F, Parnetti L, Amenta F. Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats. Brain Research. 2006;1120(1). doi:10.1016/j.brainres.2006.08.068

554. Toth K, King B. Intellectual Disability (Mental Retardation). Published online October 1, 2009. doi:10.1176/appi.books.9781585623921.md12

555. Tuboly E, Gaspar R, Ibor M, et al. l-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes: a double-edged sword phenomenon. Molecular and Cellular Biochemistry. 2019;460(1-2). doi:10.1007/s11010-019-03580-1

556. Türközü D, Sanlier N. L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Critical Reviews in Food Science and Nutrition. 2015;57(8). doi:10.1080/10408398.2015.1016141

557. Tyrer F, McGrother C. Cause-specific mortality and death certificate reporting in adults with moderate to profound intellectual disability. Journal of Intellectual Disability Research. 2009;53(11). doi:10.1111/j.1365-2788.2009.01201.x

558. Tyurenkov I, Kurkin D, Kalatanova A, et al. Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2020;120(8). doi:10.17116/jnevro202012008183

559. Uddin Md, Mamun A, Iqbal M, et al. Analyzing Nootropic Effect of &;lt;i&;gt;Phyllanthus reticulatus&;lt;/i&;gt; Poir. on Cognitive Functions, Brain Antioxidant Enzymes and Acetylcholinesterase Activity against Aluminium-Induced Alzheimer’s Model in Rats: Applicable for Controlling the Risk Factors of Alzheimer’s Disease. Advances in Alzheimer's Disease. 2016;05(03). doi:10.4236/aad.2016.53007

560. Ulhaq Z, Soraya G. Roles of IL-8 -251A/T and +781C/T polymorphisms, IL-8 level, and the risk of age-related macular degeneration. Archivos de la Sociedad Espa\~nola de Oftalmolog\’\ia (English Edition). 2021;96(9). doi:10.1016/j.oftale.2020.02.017

561. Urban K, Gao WJ. Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Frontiers in Systems Neuroscience. 2014;8. doi:10.3389/fnsys.2014.00038

562. Vaglenova J, Pandiella N, Wijayawardhane N, et al. Aniracetam Reversed Learning and Memory Deficits Following Prenatal Ethanol Exposure by Modulating Functions of Synaptic AMPA Receptors. Neuropsychopharmacology. 2007;33(5). doi:10.1038/sj.npp.1301496

563. VANCE J, STEENBERGEN R. Metabolism and functions of phosphatidylserine. Progress in Lipid Research. 2005;44(4). doi:10.1016/j.plipres.2005.05.001

564. Vance J, Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2013;1831(3). doi:10.1016/j.bbalip.2012.08.016

565. Varadarajan S, Yatin S, Aksenova M, Butterfield D. Review: Alzheimer's Amyloid \upbeta-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity. Journal of Structural Biology. 2000;130(2-3). doi:10.1006/jsbi.2000.4274

566. Veinberg G, Vavers E, Orlova N, et al. Stereochemistry of phenylpiracetam and its methyl derivative: improvement of the pharmacological profile. Chemistry of Heterocyclic Compounds. 2015;51(7). doi:10.1007/s10593-015-1747-9

567. Vellas BJ. The Geriatrician, the Primary Care Physician, Aducanumab and the FDA Decision: From Frustration to New Hope. The journal of nutrition, health & aging. 2021;25(7):821-823.

568. Volkova A, Shadrina M, Kolomin T, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology. 2016;7. doi:10.3389/fphar.2016.00031

569. Volodina M, Sebentsova E, Glazova N, et al. Correction of Long-Lasting Negative Effects of Neonatal Isolation in White Rats Using Semax. Acta Naturae. 2012;4(1). doi:10.32607/20758251-2012-4-1-86-92

570. Vuong Q, Bowyer M, Roach P. L-Theanine: properties, synthesis and isolation from tea. Journal of the Science of Food and Agriculture. 2011;91(11). doi:10.1002/jsfa.4373

571. Vyas S, Kothari S, Kachhwaha S. Nootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease. Journal of Herbal Medicine. 2019;17-18. doi:10.1016/j.hermed.2019.100291

572. Vyunova T, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein &; Peptide Letters. 2018;25(10). doi:10.2174/0929866525666180925144642

573. Wade C, Mildon R, Matthews J. Service Delivery to Parents with an Intellectual Disability: Family-Centred or Professionally Centred? Journal of Applied Research in Intellectual Disabilities. 2007;20(2). doi:10.1111/j.1468-3148.2005.00297.x

574. Wagner U, Hirzmann J, Hintz M, et al. Characterization of the DMAE-modified juvenile excretory-secretory protein Juv-p120 of Litomosoides sigmodontis. Molecular and Biochemical Parasitology. 2011;176(2). doi:10.1016/j.molbiopara.2010.12.007

575. Wakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H. Behavioral and molecular evidence for psychotropic effects in l-theanine. Psychopharmacology. 2011;219(4). doi:10.1007/s00213-011-2440-z

576. Wallace J, McCormack J, McNulty H, et al. Choline supplementation and measures of choline and betaine status: a randomised, controlled trial in postmenopausal women. British Journal of Nutrition. 2011;108(7). doi:10.1017/s000711451100674x

577. Wang B, Zou L, Li M, Zhou L. Astrocyte: A Foe or a Friend in Intellectual Disability-Related Diseases. Frontiers in Synaptic Neuroscience. 2022;14. doi:10.3389/fnsyn.2022.877928

578. Wang C, Dong H, Liu H, et al. Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam. Journal of Pharmaceutical and Biomedical Analysis. 2020;180. doi:10.1016/j.jpba.2019.113072

579. Wang C, Li F, Guan Y, et al. Bone Marrow Stromal Cells Combined with Oxiracetam Influences the Expression of B-cell Lymphoma 2 in Rats with Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 2014;23(10). doi:10.1016/j.jstrokecerebrovasdis.2014.05.035

580. Wang D, Wei Y, Tian J, et al. Oxiracetam Mediates Neuroprotection Through the Regulation of Microglia Under Hypoxia-Ischemia Neonatal Brain Injury in Mice. Molecular Neurobiology. 2021;58(8). doi:10.1007/s12035-021-02376-z

581. Wang H, Chang J, Guo Z, Li B. In silico-initiated cloning and molecular characterization of cortexin 3, a novel human gene specifically expressed in the kidney and brain, and well conserved in vertebrates. International Journal of Molecular Medicine. Published online October 1, 2007. doi:10.3892/ijmm.20.4.501

582. Wang J, Sun R, Li Z, Pan Y. Combined bone marrow stromal cells and oxiracetam treatments ameliorates acute cerebral ischemia/reperfusion injury through TRPC6. Acta Biochimica et Biophysica Sinica. 2019;51(8). doi:10.1093/abbs/gmz059

583. Wang L, Zhan Y. A conceptual peer review model for arXiv and other preprint databases. Learned Publishing. Published online February 1, 2019. doi:10.1002/leap.1229

584. Wang L, Lu C, Yang S, et al. A fully biodegradable and self-electrified device for neuroregenerative medicine. Science Advances. 2020;6(50). doi:10.1126/sciadv.abc6686

585. WANG R, YAN H, TANG X can. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1. Acta Pharmacologica Sinica. 2006;27(1). doi:10.1111/j.1745-7254.2006.00255.x

586. Wang Z, Hazen J, Jia X, et al. The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. International Journal of Molecular Sciences. 2021;22(24). doi:10.3390/ijms222413477

587. Wang ZZ, Chen JM, Lu TB. Enhancing the Hygroscopic Stability ofiS/i-Oxiracetam via Pharmaceutical Cocrystals. Crystal Growth &; Design. 2012;12(9). doi:10.1021/cg300757k

588. Warad V, Chakraborty M, Habbu P, et al. Preparation and screening of Swarnaprashana for nootropic activity. International Journal of Nutrition, Pharmacology, Neurological Diseases. 2014;4(3). doi:10.4103/2231-0738.132677

589. Weng P, Yin X, Yang S, et al. Functionalized magnesium hydroxide fluids/acrylate-coated hybrid cotton fabric with enhanced mechanical, flame retardant and shape-memory properties. Cellulose. 2017;25(2). doi:10.1007/s10570-017-1611-4

590. Weshahy S, Yehia A, Helmy A, Youssef N, Hassan S. Comparative kinetic studies and pH-rate profiling of aniracetam degradation using validated stability-indicating RP-HPLC method. Microchemical Journal. 2020;157. doi:10.1016/j.microc.2020.105047

591. Whitehouse R, Tudway J, Look R, Kroese B. Adapting Individual Psychotherapy for Adults with Intellectual Disabilities: A Comparative Review of the Cognitive-Behavioural and Psychodynamic Literature. Journal of Applied Research in Intellectual Disabilities. 2006;19(1). doi:10.1111/j.1468-3148.2005.00281.x

592. Wijayawardhane N, Shonesy B, Vaglenova J, et al. Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission. Neurobiology of Disease. 2007;26(3). doi:10.1016/j.nbd.2007.03.009

593. Wijayawardhane N, Shonesy B, Vaithianathan T, et al. Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity. Neurobiology of Disease. 2008;29(1). doi:10.1016/j.nbd.2007.08.001

594. Wilcox J, Skye S, Graham B, et al. Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial. The American Journal of Medicine. 2021;134(9). doi:10.1016/j.amjmed.2021.03.016

595. Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: A randomized, placebo-controlled study. Neurology. 2003;61(4). doi:10.1212/01.wnl.0000078943.50032.fc

596. Will B, Galani R, Kelche C, Rosenzweig M. Recovery from brain injury in animals: relative efficacy of environmental enrichment, physical exercise or formal training (1990-2002). Progress in Neurobiology. 2004;72(3). doi:10.1016/j.pneurobio.2004.03.001

597. Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS drug reviews. 2005;11(2):169-182.

598. Winter C, Jansen A, Evenhuis H. Physical conditions and challenging behaviour in people with intellectual disability: a systematic review. Journal of Intellectual Disability Research. 2011;55(7). doi:10.1111/j.1365-2788.2011.01390.x

599. Wong KH, Naidu M, David R, Bakar R, Sabaratnam V. Neuroregenerative Potential of Lion's Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Higher Basidiomycetes), in the Treatment of Peripheral Nerve Injury (Review). International Journal of Medicinal Mushrooms. 2012;14(5). doi:10.1615/intjmedmushr.v14.i5.10

600. Wood S, Wetzel R, Martin J, Hurle M. Prolines and Aamyloidogenicity in Fragments of the Alzheimer's Peptide .beta./A4. Biochemistry. 1995;34(3). doi:10.1021/bi00003a003

601. Wu SX, Cui TT, Zhao C, et al. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma. Radiotherapy and Oncology. 2010;97(1). doi:10.1016/j.radonc.2010.08.003

602. Wu Y, Funato Y, Meschi E, Jovanoski K, Miki H, Waddell S. Magnesium efflux from Drosophila Kenyon cells is critical for normal and diet-enhanced long-term memory. eLife. 2020;9. doi:10.7554/elife.61339

603. Wu Y, Tibrewal N, Birge R. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends in Cell Biology. 2006;16(4). doi:10.1016/j.tcb.2006.02.003

604. Wyss-Coray T, Rogers J. Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature. Cold Spring Harbor Perspectives in Medicine. 2011;2(1). doi:10.1101/cshperspect.a006346

605. Xiao YH, Ma S, Chen JH, Chai ZG, Li F, Wang YJ. Antibacterial activity and bonding ability of an adhesive incorporating an antibacterial monomer DMAE-CB. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009;90B(2). doi:10.1002/jbm.b.31350

606. Xiaodong S, Ying L, Fagen L, Yangqin L, Zhenghua S. Subnanogram Determination of Aniracetam in Pharmaceutical Preparations and Biofluids by Flow Injection Analysis with Chemiluminescence Detection Based on Its Enhancement of the Myoglobin-Luminol Reaction. Journal of AOAC International. 2011;94(5). doi:10.5740/jaoacint.10-175

607. Xiong Y, Lu D, Qu C, et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. Journal of Neurosurgery. 2008;109(3). doi:10.3171/jns/2008/109/9/0510

608. Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opinion on Emerging Drugs. 2009;14(1). doi:10.1517/14728210902769601

609. Xu J, Qi Q, Lv P, Dong Y, Jiang X, Liu Z. Oxiracetam ameliorates cognitive deficits in vascular dementia rats by regulating the expression of neuronal apoptosis/autophagy-related genes associated with the activation of the Akt/mTOR signaling pathway. Brazilian Journal of Medical and Biological Research. 2019;52(11). doi:10.1590/1414-431x20198371

610. Yakovlev AA, Lyzhin AA, Khaspekov LG, Guekht AB, Gulyaeva NV. [Peptide drug cortexin inhibits brain caspase-8]. Biomed Khim. 2017;63(1):27-31. doi:10.18097/PBMC2017630127

611. Yakovlev A, Gulyaeva N. Molecular partners of Cortexin in the brain. Neurochemical Journal. 2017;11(1). doi:10.1134/s1819712416040164

612. Yakovlev A, Lyzhin A, Khaspekov L, Guekht A, Gulyaeva N. Peptide drug cortexin inhibits brain caspase-8. Biomeditsinskaya Khimiya. 2017;63(1). doi:10.18097/pbmc20176301027

613. Yao X li, Yao ZH, Li L, Nie L, Zhang S feng. Oxiracetam can improve cognitive impairment after chronic cerebral hypoperfusion in rats. Psychiatry Research. 2016;246. doi:10.1016/j.psychres.2016.10.006

614. Yatsenko K, Glazova N, Inozemtseva L, et al. Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats. Doklady Biological Sciences. 2013;453(1). doi:10.1134/s0012496613060161

615. Yeung T, Gilbert G, Shi J, Silvius J, Kapus A, Grinstein S. Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization. Science. 2008;319(5860). doi:10.1126/science.1152066

616. Yilmaz Z, Ozarda Y, Cansev M, Eralp O, Kocaturk M, Ulus I. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia. Blood Coagulation &; Fibrinolysis. 2010;21(4). doi:10.1097/mbc.0b013e328338ce31

617. Yin D, Cui D, Gao F, et al. A Rapid and Sensitive Chemiluminescent Immunoassay of Total Thyroxin with DMAE~\cdotp~NHS-Labeled. Journal of Immunoassay and Immunochemistry. 2008;29(3). doi:10.1080/15321810802119075

618. Yin S, Ran Q, Yang J, Zhao Y, Li C. Nootropic effect of neferine on aluminium chloride-induced Alzheimer's disease in experimental models. Journal of Biochemical and Molecular Toxicology. 2019;34(2). doi:10.1002/jbt.22429

619. Yoto A, Motoki M, Murao S, Yokogoshi H. Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. Journal of Physiological Anthropology. 2012;31(1). doi:10.1186/1880-6805-31-28

620. Yu Y. Aniracetam. Published online October 1, 2013. doi:10.1002/9781118541203.xen110

621. Zadehdarvish F, Kesmati M, Khajehpour L, Torabi M. Effects of magnesium oxide nanoparticles on memory impairment induced by postpartum depression model. Physiology and Pharmacology. Published online December 1, 2019. doi:10.32598/ppj.24.1.80

622. Zafarani-Moattar M, Shekaari H, Jafari P. Thermodynamics of acetaminophen and bovine serum albumin partitioning in ternary aqueous solutions comprising polyethylene glycol dimethyl ether 250 and choline bitartrate: Liquid-liquid equilibria, volumetric and acoustic investigations. Journal of Molecular Liquids. 2021;323. doi:10.1016/j.molliq.2020.115072

623. Zafarani-Moattar M, Shekaari H, Pourbagherian E. Study of the liquid-liquid equilibrium for aqueous ternary systems containing choline bitartrate and 1-propanol or 2-propanol at different temperatures and their performances in acetaminophen separation and alcohols recovery. Fluid Phase Equilibria. 2020;514. doi:10.1016/j.fluid.2020.112536

624. Zalyalyutdinova L, Fardieva R, Gaynetdinova A. THE STUDY OF NEUROTROPIC PROPERTIES OF LIPOIC ACID IN THE EXPERIMENT. Современные проблемы науки и образования  (Modern Problems of Science and Education). 2014; 6 2014). doi:10.17513/spno.16847

625. Zarate C, Singh J, Quiroz J, et al. A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression. American Journal of Psychiatry. 2006;163(1). doi:10.1176/appi.ajp.163.1.153

626. Zhang C, Chopp M, Cui Y, et al. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. Journal of neuroscience research. 2010;88(15):3275-3281.

627. Zhang H, Jia L, Jia J. Oxiracetam Offers Neuroprotection by Reducing Amyloid \upbeta-Induced Microglial Activation and Inflammation in Alzheimer's Disease. Frontiers in Neurology. 2020;11. doi:10.3389/fneur.2020.00623

628. Zhang J, Wei J, Li B, Zhao X, Zhang J. Long-term corrosion protection for magnesium alloy by two-layer self-healing superamphiphobic coatings based on shape memory polymers and attapulgite. Journal of Colloid and Interface Science. 2021;594. doi:10.1016/j.jcis.2021.03.005

629. Zhang J, Liang J, Tian Y, Zhang Z, Chen Y. Sensitive and selective liquid chromatography-tandem mass spectrometry method for the quantification of aniracetam in human plasma. Journal of Chromatography B. 2007;858(1-2). doi:10.1016/j.jchromb.2007.08.010

630. Zhang J, Mai CL, Xiong Y, et al. The Causal Role of Magnesium Deficiency in the Neuroinflammation, Pain Hypersensitivity and Memory/Emotional Deficits in Ovariectomized and Aged Female Mice. Journal of Inflammation Research. 2021;Volume 14. doi:10.2147/jir.s330894

631. Zhang K, Liu Y, Wang X. Enzymatic preparation of L -α-glycerylphosphorylcholine in an aqueous medium. European Journal of Lipid Science and Technology. 2012;114(11). doi:10.1002/ejlt.201100219

632. Zhang K, Wang X, Huang J, Liu Y. Purification of l-alpha glycerylphosphorylcholine by column chromatography. Journal of Chromatography A. 2012;1220. doi:10.1016/j.chroma.2011.12.003

633. Zhang K, Wang X, Liu Y. Aqueous medium enzymatic preparation of l-alpha glycerylphosphorylcholine optimized by response surface methodology. European Food Research and Technology. 2012;234(3). doi:10.1007/s00217-011-1655-x

634. Zhang L, Chopp M, Wang C, et al. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke. Journal of the Neurological Sciences. 2019;398. doi:10.1016/j.jns.2019.01.017

635. Zhang S, Iwata K, Lachenmann M, et al. The Alzheimer's Peptide A\upbeta Adopts a Collapsed Coil Structure in Water. Journal of Structural Biology. 2000;130(2-3). doi:10.1006/jsbi.2000.4288

636. Zhang Y, Chopp M, Meng Y, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. Journal of Neurosurgery. 2015;122(4). doi:10.3171/2014.11.jns14770

637. Zhang Y, Chopp M, Zhang Z, et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochemistry International. 2017;111. doi:10.1016/j.neuint.2016.08.003

638. Zhaoxin G, Han L, Zhijiang Z, Libo P. Design a Robot System for Tomato Picking Based on YOLO v5. IFAC-PapersOnLine. 2022;55(3). doi:10.1016/j.ifacol.2022.05.029

639. Zhu G, Wang Y, Li J, Wang J. Chronic treatment with ginsenoside Rg1 promotes memory and hippocampal long-term potentiation in middle-aged mice. Neuroscience. 2015;292. doi:10.1016/j.neuroscience.2015.02.031

640. Ziegler D, Movsesyan L, Mankovsky B, Gurieva I, Abylaiuly Z, Strokov I. Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients. Diabetes Care. 2009;32(8). doi:10.2337/dc09-0545

641. Zirah S, Kozin S, Mazur A, et al. Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid \upbeta-Peptide upon Zinc Binding and in Vitro Aging. Journal of Biological Chemistry. 2006;281(4). doi:10.1074/jbc.m504454200

642. Zvejniece L, Svalbe B, Vavers E, et al. S -phenylpiracetam, a selective DAT inhibitor, reduces body weight gain without influencing locomotor activity. Pharmacology Biochemistry and Behavior. 2017;160. doi:10.1016/j.pbb.2017.07.009

643. Zvejniece L, Zvejniece B, Videja M, et al. Neuroprotective and anti-inflammatory activity of DAT inhibitor R-phenylpiracetam in experimental models of inflammation in male mice. Inflammopharmacology. 2020;28(5). doi:10.1007/s10787-020-00705-7

644. Zwaal R, Comfurius P, Bevers E. Surface exposure of phosphatidylserine in pathological cells. CMLS Cellular and Molecular Life Sciences. 2005;62(9). doi:10.1007/s00018-005-4527-3

645. Zykov V, Serebrennikova E, Panchenko T, et al. Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2018;118(3). doi:10.17116/jnevro20181183127-31

646. Office of Dietary Supplements - Daily Values (DVs). Accessed December 18, 2022. https://ods.od.nih.gov/HealthInformation/dailyvalues.aspx/

647. Hansl v. Creighton University. Justia Law. Published 1993. Accessed December 12, 2022. https://law.justia.com/cases/nebraska/supreme-court/1993/1066-0.html

648. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to... - Abstract - Europe PMC. Published October 17, 2018. Accessed October 17, 2018. https://europepmc.org/abstract/med/22514792